rfhg_82317.1

Basic information about the TSS

---

TSS ID: rfhg_82317.1 Species: human Chr: chr6		Start: 37819401 End: 37819417 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3838122,EH38E2464614)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000287218.9:310 GeneID: 60685 HGNC/MGI_ID: HGNC:18019 UniProt_ID: A0A024RD12 Nearer transcript ids and distances: ENST00000373391.6:381 AK023284:440 BC031481:498 view more...

Gene_name: zinc finger AN1-type containing 3 Gene_symbol: ZFAND3 Gene_synonyms: FLJ13222 Gene_source: HGNC:18019

TATA-Box annotation

---

Distance to TSS:	-318
Nearest PromoterID:	NM_021943
Entrez ID:	60685
Nearest Unigene:	Hs.36959
Nearest Refseq:	NM_021943
Nearest Ensembl:	ENSG00000156639
Gene Name:	zinc finger AN1-type containing 3
Gene Alias:	TEX27
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.647059
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZFAND3 p2@ZFAND3 p3@ZFAND3 p4@ZFAND3 p5@ZFAND3 p6@ZFAND3 p7@ZFAND3 p8@ZFAND3 p9@ZFAND3 p10@ZFAND3
Sample		p1@ZFAND3	p2@ZFAND3	p3@ZFAND3	p4@ZFAND3	p5@ZFAND3	p6@ZFAND3	p7@ZFAND3	p8@ZFAND3	p9@ZFAND3	p10@ZFAND3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.19	2.53	2.53	0.19	6.04	3.51	0.39	0.39	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	25.69	2.83	3.44	0.40	3.24	2.83	0.20	0.61	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	24.50	3.28	0.96	1.74	4.05	2.51	0.00	0.96	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.75	2.49	1.46	0.62	6.24	2.91	0.62	0.83	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.75	2.47	1.80	0.90	5.62	2.47	0.22	0.67	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	21.51	1.16	1.94	1.16	5.04	1.36	0.00	0.58	0.00	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	29.63	4.58	2.18	2.40	3.49	2.61	0.65	0.65	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.28	4.36	1.21	0.97	3.39	1.70	0.24	0.24	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.35	2.99	3.21	1.07	4.70	2.35	1.07	0.85	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.15	4.64	3.48	5.22	10.43	3.48	1.74	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	46.08	6.47	2.02	2.02	10.51	2.02	0.81	0.81	0.40	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.17	3.66	0.81	2.85	16.26	4.88	1.63	2.03	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	48.04	5.64	2.74	5.00	1.13	2.10	1.61	0.48	0.16	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	40.29	5.41	1.80	4.66	1.20	2.56	0.75	0.45	0.45	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	56.21	7.25	3.07	5.27	1.54	3.07	1.32	0.22	0.22	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	39.23	4.53	3.02	4.78	0.75	3.27	1.26	0.00	0.50	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	39.97	4.15	1.97	3.71	1.75	1.75	1.09	0.00	0.00	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	39.23	3.80	3.37	6.33	0.42	3.37	1.27	0.42	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	2.67	2.67	5.33	1.60	1.07	0.53	0.53	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.95	6.92	2.86	5.57	0.90	3.01	1.20	0.45	0.30	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	36.75	6.01	2.67	3.88	0.94	2.27	1.20	0.13	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.04	6.21	2.93	3.80	0.69	1.73	0.52	0.86	0.52	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.38	4.52	1.94	4.78	1.29	2.59	0.26	0.26	0.90	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.40	6.31	1.94	4.13	1.21	1.46	0.00	0.49	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.47	6.71	1.81	4.64	1.55	2.32	0.52	0.52	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.45	4.43	2.53	5.70	0.95	2.22	0.32	0.00	0.95	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	4.95	1.10	3.30	1.10	2.20	1.65	1.10	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.44	5.42	1.41	4.01	1.18	3.30	0.94	0.47	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.40	5.33	2.10	4.04	0.97	2.91	0.48	0.32	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.30	6.88	3.44	4.34	1.09	2.17	1.09	0.36	0.72	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	6.70	2.51	2.72	2.09	1.88	0.21	0.00	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	28.33	5.86	3.32	1.95	1.95	2.93	0.59	0.39	0.59	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.23	6.54	3.17	5.70	1.48	1.90	0.84	0.00	0.21	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.25	5.11	1.81	4.95	0.16	1.32	0.16	0.00	0.33	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.54	5.24	2.62	4.11	1.50	2.99	1.31	0.37	0.19	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.01	6.90	2.11	3.26	1.34	3.83	0.57	0.19	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	40.47	6.34	2.25	4.29	1.02	1.84	0.82	0.20	0.20	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.45	5.64	1.61	4.03	0.81	2.42	0.40	0.00	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.27	6.75	4.86	4.86	4.32	4.32	1.08	0.00	0.54	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.53	7.68	1.44	5.04	1.68	3.36	0.72	0.00	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.17	4.47	1.41	4.00	1.65	0.47	0.94	0.00	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	27.38	5.56	2.20	4.39	1.32	2.20	0.29	0.44	0.29	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.07	8.86	3.59	4.64	1.69	2.11	1.05	0.00	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.76	6.64	1.75	2.27	1.05	3.15	0.35	0.35	0.35	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	47.58	4.62	3.01	3.01	2.41	2.41	1.00	0.40	0.40	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.46	9.31	3.95	3.72	2.09	1.63	1.16	0.70	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	45.10	5.28	2.40	4.56	3.36	2.64	1.20	0.24	0.48	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.39	9.84	3.58	4.47	1.19	2.09	1.79	0.30	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.13	5.98	1.91	2.15	2.15	2.39	1.91	0.00	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.82	5.26	3.44	4.04	2.63	3.44	1.21	0.40	0.20	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.49	2.25	3.89	2.25	2.66	1.64	1.23	0.20	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.02	3.11	3.34	1.78	2.45	3.34	0.44	0.22	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.74	4.26	2.48	0.71	0.35	1.42	0.71	0.00	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.49	2.32	2.65	2.32	1.33	1.99	1.33	0.33	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32.72	3.36	1.68	2.52	2.52	0.84	0.84	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	20.21	0.92	1.84	3.21	2.30	1.38	0.92	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	31.11	1.62	1.94	1.30	2.27	3.89	0.65	0.32	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.30	3.53	1.93	0.64	2.57	4.82	0.96	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.83	2.83	2.20	2.20	1.26	2.20	0.94	0.31	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	4.94	2.82	0.71	2.82	2.12	0.71	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	36.45	5.05	1.68	2.24	1.68	2.24	0.56	0.56	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	52.55	0.80	9.55	0.80	3.18	1.59	0.80	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	1.36	2.72	0.68	2.04	3.40	0.68	0.00	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	33.79	1.30	3.57	0.97	3.57	1.30	0.32	0.65	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.17	3.90	1.42	1.77	2.84	2.13	0.35	1.06	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.15	4.88	2.93	0.98	0.98	0.98	0.49	0.00	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.27	6.45	0.99	0.50	0.50	0.00	0.99	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.09	2.35	0.47	0.47	1.41	0.47	0.47	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	2.65	2.65	1.99	0.33	0.99	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	32.48	4.33	1.55	1.24	3.09	0.31	0.31	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.33	5.50	0.92	2.14	0.31	0.61	0.61	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	38.49	3.01	2.38	1.90	1.11	0.95	1.90	0.32	1.74	0.32
Adipocyte - breast, donor2	11327-117E4	42.35	3.21	2.73	2.41	1.28	1.12	1.12	0.16	0.16	0.96
Adipocyte - omental, donor1	11473-119C6	51.15	6.36	3.31	3.18	1.15	2.16	1.02	0.38	0.76	0.25
Adipocyte - omental, donor2	11474-119C7	34.38	4.48	0.00	1.49	1.49	0.00	1.49	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	41.53	6.36	2.01	3.35	1.67	0.33	3.01	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	38.28	3.83	2.55	1.91	0.64	0.64	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	32.99	0.00	2.20	1.10	2.20	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	29.81	4.52	0.90	1.35	0.45	0.45	0.90	0.45	2.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	47.96	2.78	0.87	2.43	0.87	0.17	1.04	0.17	0.35	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	87.23	3.32	4.69	6.26	2.54	5.48	1.17	0.39	0.39	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	47.36	4.63	4.12	3.35	2.57	2.57	1.29	0.51	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	66.91	4.18	3.62	3.07	1.12	4.46	1.12	1.12	1.12	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	64.07	2.94	5.29	3.53	1.76	3.53	0.59	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	53.01	3.22	4.99	3.78	2.73	4.83	0.97	0.56	0.32	1.45
Adipocyte differentiation, day08, donor2	13023-139D8	55.19	2.58	2.58	2.90	0.65	2.58	0.65	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	36.79	3.20	1.60	2.13	2.67	0.53	2.67	0.00	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	2.78	3.34	2.78	2.23	1.11	0.00	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	35.35	0.83	2.50	2.91	2.08	0.83	2.08	0.42	0.42	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	35.16	2.51	1.76	1.76	2.26	1.00	1.26	0.25	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	1.31	4.25	0.98	0.33	2.62	0.65	0.33	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	44.15	1.83	3.35	1.83	1.83	2.13	0.30	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	43.09	1.77	3.09	1.10	4.20	3.09	0.00	0.66	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	36.22	2.15	2.15	1.43	2.87	2.15	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	41.93	3.59	1.20	3.59	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	35.80	1.08	2.70	0.36	1.80	2.16	0.00	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	53.55	1.67	3.35	0.00	0.00	5.02	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	53.01	1.23	3.08	0.62	1.23	1.85	0.00	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	40.39	2.17	0.80	4.00	0.92	2.75	0.11	0.23	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	48.25	5.14	1.47	4.41	0.49	1.96	0.24	0.49	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.81	1.35	1.80	2.70	0.00	0.45	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	34.30	0.87	2.60	1.74	1.74	0.87	0.87	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.19	0.60	1.20	1.79	0.30	2.09	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	3.79	1.26	0.00	2.53	3.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	0.66	1.32	1.32	1.32	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.04	1.95	0.65	1.95	1.30	0.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	1.46	2.43	0.49	0.97	3.88	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	18.41	1.19	1.19	1.19	1.78	1.19	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	34.65	1.13	0.75	1.13	1.51	0.75	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	1.45	2.90	2.18	2.18	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	0.00	1.25	1.25	0.00	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	31.96	1.15	2.47	1.48	1.32	0.99	0.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	1.36	6.82	0.00	1.36	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.81	1.51	1.21	1.21	0.45	0.90	0.15	0.15	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	2.68	1.07	1.07	3.75	0.54	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.06	1.70	2.65	1.70	0.57	2.46	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.80	1.34	1.34	1.34	0.80	2.41	0.53	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	1.95	2.93	2.93	0.98	2.93	0.98	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.20	1.49	3.15	1.33	1.49	1.49	0.17	0.17	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	1.20	2.40	0.00	1.20	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	0.00	7.08	7.08	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	34.31	2.40	2.23	1.37	0.86	1.54	0.34	0.17	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.67	2.91	2.43	0.49	0.00	2.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	35.67	1.52	1.90	0.76	0.76	0.76	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	0.00	1.21	2.42	2.42	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.21	0.57	0.57	0.57	1.71	2.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.29	1.71	1.71	1.50	1.07	1.50	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.42	1.03	0.77	1.55	1.03	0.77	0.26	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	31.91	0.47	2.35	1.88	0.94	1.41	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	35.37	1.29	1.29	1.93	0.96	1.61	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	1.43	1.43	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	25.74	1.75	4.09	0.58	0.58	2.34	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.99	2.41	0.60	0.90	1.51	2.41	0.30	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	1.19	0.00	0.00	1.19	0.00	2.38	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	1.53	1.02	2.03	2.03	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	27.00	2.55	1.78	0.76	1.02	1.78	0.51	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	1.91	0.00	1.27	1.27	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.48	1.73	2.16	1.29	0.86	1.29	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.19	1.91	1.91	1.48	0.64	0.42	0.85	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.40	0.58	1.74	0.87	0.58	0.87	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	41.57	0.00	2.83	0.94	0.94	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	30.85	1.19	1.53	1.70	0.51	1.36	0.34	0.34	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	2.11	2.11	0.00	2.11	6.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	29.16	1.29	1.93	2.36	1.29	2.36	0.21	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.64	3.01	2.41	0.60	0.00	0.60	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	25.51	2.92	3.64	0.73	0.73	3.64	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.10	1.38	1.38	0.69	0.46	1.38	0.69	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	0.00	2.55	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	25.42	1.02	1.27	1.02	1.27	1.53	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.24	2.68	2.68	2.48	1.45	0.83	0.00	0.00	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.50	1.22	2.14	1.53	1.84	1.53	0.00	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.46	0.48	2.39	0.96	1.43	3.35	0.00	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.83	3.33	1.77	2.44	0.89	2.22	0.44	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	1.53	1.53	0.00	3.05	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	2.77	0.55	0.55	2.77	1.66	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.54	1.85	1.85	2.12	1.59	1.32	0.26	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	1.09	1.45	0.73	0.73	0.00	0.00	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	43.60	6.02	4.67	3.44	2.70	3.93	0.25	0.25	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	41.08	5.48	3.77	2.91	1.54	1.88	0.00	0.51	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	47.82	11.12	4.61	8.39	3.99	1.89	0.00	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	64.14	4.88	6.62	3.83	5.93	1.39	0.35	0.00	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	52.41	6.79	6.31	3.88	7.12	3.88	0.00	0.00	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	56.08	8.05	6.12	6.56	4.92	5.37	0.45	0.60	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	69.96	2.18	5.39	1.49	1.38	3.67	0.34	0.57	0.23	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	68.78	1.88	4.13	0.75	1.38	3.76	0.38	0.50	0.25	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	61.79	0.91	3.87	0.57	1.37	3.41	0.11	0.34	0.00	0.57
Basophils, donor1	12241-129G9	65.12	1.83	2.35	0.52	2.09	2.62	0.26	0.52	0.00	0.26
Basophils, donor2	12242-129H1	77.21	0.72	1.80	0.00	0.72	3.97	1.08	0.72	0.00	0.72
Basophils, donor3	12243-129H2	104.66	1.47	2.35	1.62	1.32	2.50	1.03	0.29	0.15	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	37.30	0.86	3.02	0.43	2.16	1.08	0.00	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	29.72	2.74	1.83	0.00	0.91	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	19.46	0.00	1.26	0.00	1.26	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	28.49	0.83	2.08	1.04	0.83	0.62	0.83	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	48.36	3.68	2.76	1.15	0.23	1.15	0.00	0.23	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	29.33	0.72	2.52	0.72	0.00	0.90	0.00	0.18	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	21.74	1.24	0.93	1.03	0.62	1.13	0.31	0.31	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	36.33	0.93	1.63	0.93	1.63	2.10	0.23	0.23	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	45.09	0.64	2.24	0.32	1.60	1.92	0.00	1.28	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	0.00	0.00	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	147.65	0.56	5.07	2.25	3.38	2.82	1.13	1.13	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	182.26	2.60	4.83	2.04	2.41	4.08	0.37	0.74	0.19	0.93
CD14+ Monocytes, donor3	11381-118B4	173.65	1.54	8.34	1.98	6.15	4.17	0.22	1.54	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.14	2.83	2.83	4.25	0.85	2.26	1.42	0.28	1.13	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	85.67	3.41	3.03	4.17	1.52	1.90	0.38	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	113.74	4.93	5.59	5.59	1.31	3.62	0.33	0.00	0.99	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	82.97	4.34	4.34	2.89	1.88	2.60	2.89	0.58	0.43	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	71.21	3.32	3.32	2.41	0.91	2.72	0.91	0.30	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	89.55	3.32	3.79	2.61	1.90	3.08	2.13	0.24	0.24	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	53.90	2.18	2.85	0.67	2.18	2.34	1.34	0.50	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.30	1.66	1.66	1.38	1.66	1.93	0.00	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	68.43	1.98	1.74	1.49	3.97	2.73	0.25	0.25	0.25	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	57.57	1.57	2.55	1.57	0.98	1.57	0.20	0.20	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	57.87	0.71	2.49	0.53	1.42	0.53	0.18	0.18	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.50	0.65	2.39	1.31	3.05	0.65	0.22	0.22	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	66.26	0.94	3.28	1.17	2.58	1.87	0.47	0.70	0.94	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	92.93	1.58	4.75	2.11	5.28	2.64	0.00	0.00	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	86.53	2.22	3.33	2.22	1.11	1.11	0.00	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	62.62	3.57	3.27	2.68	1.49	1.93	1.34	0.45	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	54.68	1.20	3.19	2.00	3.19	1.80	1.00	0.60	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	42.68	1.04	1.67	0.62	2.29	1.46	0.00	0.00	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	69.78	2.06	2.75	1.60	2.75	2.52	0.46	0.23	0.69	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	51.35	0.45	1.13	0.90	3.62	1.13	1.13	0.45	1.36	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	63.29	0.87	5.24	0.87	2.62	2.18	0.87	0.44	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	50.84	1.88	3.77	1.61	1.34	1.08	0.54	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	67.87	1.92	1.92	2.62	1.92	2.44	0.87	0.17	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	74.49	2.10	2.10	1.26	3.79	2.10	2.10	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	81.38	1.10	2.39	1.65	3.67	2.94	0.73	0.37	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	79.96	2.82	4.93	0.35	6.34	3.52	0.70	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	108.80	2.63	5.26	2.63	7.02	6.58	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	65.56	0.70	2.44	1.22	2.62	2.96	0.17	0.52	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	64.30	0.00	3.35	0.74	2.23	1.49	0.74	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	59.49	1.51	2.37	1.08	3.02	1.72	0.43	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	71.66	2.87	3.69	1.64	2.87	1.64	0.00	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	59.34	1.16	2.55	0.46	5.10	2.32	0.23	0.70	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	56.37	0.93	2.09	0.46	4.41	1.39	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	32.91	0.22	0.87	0.00	0.87	1.96	0.44	0.44	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	56.36	1.15	1.39	1.62	1.15	1.62	0.00	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	49.39	0.00	1.52	0.22	1.30	1.73	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	92.34	0.93	4.05	1.09	1.40	2.65	0.16	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	75.80	1.22	1.92	0.17	1.40	2.97	0.00	0.52	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	121.30	1.56	2.68	0.67	2.01	4.24	0.45	0.89	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	51.29	0.00	2.30	1.02	1.79	2.55	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	56.65	0.44	2.85	1.10	1.10	2.42	0.22	1.54	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	47.16	0.42	2.32	0.63	1.05	2.32	0.00	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	2.03	0.00	2.03	0.00	0.00	0.00	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	55.59	0.68	3.39	0.00	0.00	2.03	0.00	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	0.00	2.07	0.00	0.00	4.14	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	65.03	0.53	5.86	0.53	4.80	2.67	0.53	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.30	0.54	4.29	0.54	0.00	3.75	0.00	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	59.66	0.70	3.51	0.00	1.40	2.11	0.00	2.81	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.90	0.00	7.06	0.00	0.78	1.57	0.00	1.57	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	1.32	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	90.41	5.75	9.86	1.64	2.47	4.93	0.00	1.64	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	75.44	2.18	5.80	1.45	2.90	6.53	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	86.33	3.03	5.05	2.02	3.03	8.08	0.00	1.01	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	47.68	0.00	2.42	0.81	2.02	5.25	0.00	6.06	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	25.97	0.00	2.00	0.00	0.80	3.99	0.00	1.60	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	57.23	1.00	1.00	0.00	1.00	4.02	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	74.16	1.12	3.93	3.37	3.93	4.49	1.12	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	36.45	0.38	1.50	1.13	0.75	1.50	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	30.21	0.68	3.38	0.23	0.90	1.80	0.23	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	120.33	0.00	7.86	0.36	3.21	9.64	0.36	5.36	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	80.83	1.22	4.90	0.61	3.06	7.96	0.61	3.06	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	82.35	0.91	8.84	0.61	2.13	7.32	0.00	2.13	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.22	0.51	2.81	0.26	1.02	2.81	0.00	1.28	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.72	0.00	2.25	1.12	0.45	2.70	0.45	1.35	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	58.64	0.00	4.89	1.15	0.57	2.87	0.57	0.86	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	60.21	0.00	5.22	0.00	0.00	2.37	0.00	6.16	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	47.76	0.00	4.21	0.00	1.40	4.21	0.00	4.21	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	0.00	3.30	0.00	0.00	9.89	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.90	1.16	2.60	0.87	0.43	3.47	0.43	1.01	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	44.91	0.51	3.22	0.85	1.36	4.74	1.02	0.51	0.34	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.30	0.32	3.39	0.64	0.81	5.32	0.64	0.64	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	55.14	0.00	1.79	0.45	1.79	4.03	0.00	0.90	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.20	0.35	2.45	1.40	1.05	3.49	0.35	0.70	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	49.72	0.44	3.52	0.88	1.32	2.64	0.44	1.32	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.90	2.11	0.84	0.84	0.84	1.69	1.26	1.69	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	51.73	0.83	3.32	0.21	0.83	2.91	0.21	1.25	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	45.11	1.00	0.67	0.00	0.67	3.01	0.00	0.67	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	53.03	0.82	4.89	0.00	1.36	7.61	0.00	1.90	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	86.82	0.00	9.65	0.54	1.61	8.04	0.54	8.04	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	0.00	5.38	0.00	3.59	5.38	1.79	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	62.30	2.04	3.52	1.30	0.93	5.75	0.37	1.67	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	46.14	0.43	2.38	0.43	1.95	2.17	0.87	0.65	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	60.52	0.63	3.57	1.05	1.05	3.78	0.42	1.05	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	55.11	0.00	4.04	0.00	1.01	5.06	0.00	4.55	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	52.86	0.43	5.20	0.00	1.30	4.33	0.00	3.47	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	63.19	0.87	3.49	0.87	0.44	5.23	0.00	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	77.20	0.49	2.97	0.00	0.99	3.96	0.00	0.99	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	60.93	0.00	3.69	0.00	0.92	2.77	0.00	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	40.48	0.00	1.40	0.00	0.00	5.58	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	93.88	0.28	3.88	1.11	0.55	3.88	0.28	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	78.03	0.49	4.17	1.23	0.98	3.93	0.98	4.17	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	30.80	1.54	7.70	0.00	0.00	3.08	1.54	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	70.55	0.00	4.30	0.72	0.36	3.58	0.72	1.43	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	87.25	1.38	2.77	0.00	0.00	5.54	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	89.05	3.27	11.46	1.96	1.64	6.88	0.33	2.29	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	83.35	2.63	4.51	1.50	2.25	4.51	1.13	0.38	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	106.05	3.28	7.57	1.77	2.52	9.85	1.01	3.28	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.96	0.92	3.21	0.23	4.82	2.06	0.00	0.46	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.97	1.44	2.40	0.48	3.59	1.92	0.00	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.06	0.82	2.74	0.55	3.01	1.92	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.31	1.20	3.00	0.30	3.30	0.90	0.00	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.56	1.44	3.60	0.00	4.56	1.44	0.00	0.00	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.51	1.36	3.18	0.00	4.32	2.05	0.00	0.23	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	16.08	1.09	2.61	0.00	3.69	1.74	0.22	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.53	2.11	2.11	0.26	2.90	2.63	0.26	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.54	1.41	1.88	0.23	1.64	2.35	0.23	0.23	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.09	0.91	0.91	0.30	2.42	2.11	0.60	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.01	1.45	4.07	0.29	2.61	0.29	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.45	0.53	0.80	0.53	2.13	1.87	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	40.71	3.06	5.69	2.19	7.88	1.31	0.44	0.44	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	40.53	2.73	5.92	0.46	7.74	1.37	0.00	0.00	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	60.42	2.98	11.19	0.00	14.17	2.24	0.75	0.75	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.69	0.72	6.12	0.00	7.92	2.16	0.00	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.85	2.01	3.74	0.00	4.60	1.44	0.29	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.21	1.41	6.13	0.94	3.77	2.83	0.00	0.24	0.24	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	0.63	2.85	0.00	2.85	1.27	0.00	1.27	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.15	0.62	1.85	0.31	5.84	2.77	0.62	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	19.88	0.32	3.53	0.00	2.89	1.28	0.96	0.00	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.95	1.53	2.29	0.38	3.06	1.91	0.00	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	1.97	1.18	0.79	5.91	1.97	0.00	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	0.76	0.76	0.00	2.27	1.51	0.00	0.76	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.83	4.01	8.83	0.00	10.44	6.42	0.80	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	65.05	4.90	7.69	0.00	15.39	6.99	1.40	1.40	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	79.14	5.01	11.02	0.00	14.02	6.01	0.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	115.15	7.31	0.00	3.66	0.00	1.83	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	29.65	1.98	3.95	1.48	2.47	0.99	0.00	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	48.83	3.89	3.26	3.89	2.74	1.26	0.21	0.32	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	38.83	5.55	4.16	1.39	3.12	0.35	1.39	0.00	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	33.41	1.07	2.13	1.78	1.78	0.71	1.07	0.00	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	54.16	3.07	3.64	2.05	1.82	1.93	0.23	0.11	0.46	0.68
Chondrocyte - re diff, donor2	11339-117F7	51.92	5.37	5.37	7.16	1.79	0.90	0.00	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	69.96	4.85	2.02	3.24	1.62	1.62	0.81	0.00	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	43.84	4.93	6.66	3.56	3.90	4.02	0.00	0.69	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	44.04	3.63	5.34	3.63	2.14	2.78	0.43	0.43	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	49.56	5.58	4.60	4.25	3.27	3.19	0.18	0.18	0.00	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	94.91	15.22	27.14	13.30	28.15	11.19	0.55	1.74	0.46	3.85
Corneal Epithelial Cells, donor1	11526-119I5	55.11	2.20	3.29	1.54	2.63	1.98	0.66	0.44	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	23.89	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	48.31	0.26	2.05	2.30	1.53	1.79	0.26	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.46	0.66	3.30	1.16	2.48	2.64	0.17	0.17	0.00	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	39.11	0.32	3.78	0.63	2.21	1.58	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.70	0.86	2.92	0.32	1.40	2.38	0.43	0.43	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	67.99	2.39	2.05	1.02	2.05	4.44	0.68	3.07	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	54.84	1.31	2.61	0.65	1.31	1.96	0.65	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	52.75	1.94	2.42	0.00	0.00	2.90	0.48	3.39	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	30.19	2.50	2.00	2.67	1.50	0.67	0.00	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	36.38	2.35	0.59	3.52	5.87	1.76	0.00	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	39.31	1.70	4.52	1.41	2.83	2.55	0.00	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	44.43	2.75	5.50	0.39	3.54	2.36	0.00	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	41.01	0.87	2.62	2.04	3.49	0.58	0.00	0.00	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	45.17	0.47	3.06	1.41	2.59	2.12	0.24	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	43.13	1.05	2.80	2.45	2.98	1.93	0.00	0.18	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.56	1.77	2.66	2.44	2.22	0.66	0.00	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	51.12	2.13	4.87	2.74	5.17	2.13	0.00	0.61	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.59	1.97	5.92	0.85	4.79	2.26	0.00	0.00	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	28.82	2.97	2.38	3.57	1.49	0.89	1.19	0.30	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	27.07	2.08	2.08	1.56	1.56	0.52	0.00	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	34.88	2.84	3.40	1.70	1.42	2.41	0.43	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	44.41	2.40	0.80	1.20	2.00	1.60	0.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	34.59	3.14	3.14	1.05	3.67	1.05	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	62.00	1.62	6.46	4.97	3.98	2.73	0.50	0.50	0.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	79.30	2.61	4.35	3.69	5.43	2.17	0.43	0.00	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	73.52	1.83	5.13	3.18	4.64	4.27	0.12	0.49	0.00	0.61
Endothelial Cells - Vein, donor1	11267-116G7	25.03	3.41	1.14	2.28	0.00	5.69	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	26.54	2.79	3.49	0.00	2.79	0.70	0.00	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	38.62	2.36	3.93	2.67	2.83	2.36	0.16	0.16	0.16	0.16
Eosinophils, donor1	12244-129H3	60.99	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	547.89	11.55	28.05	16.50	21.45	9.90	1.65	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	485.09	7.13	21.40	0.00	32.10	3.57	3.57	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	32.98	0.24	0.98	0.49	0.98	1.22	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	58.24	4.16	0.00	0.00	2.08	0.00	0.00	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	62.81	4.11	4.11	2.87	2.05	1.64	0.41	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.10	1.09	1.64	1.64	1.09	1.20	1.20	0.11	1.20	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	35.64	4.01	2.17	2.82	1.52	0.76	1.08	0.43	1.30	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.57	2.91	2.18	2.79	1.21	1.94	0.49	0.12	0.85	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	50.36	1.09	3.55	0.82	1.36	1.91	0.27	0.55	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	60.64	6.54	3.38	4.43	2.53	2.00	0.53	0.00	0.74	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.95	3.16	2.37	1.84	1.05	1.05	0.79	0.53	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	52.82	4.32	3.65	3.65	1.99	0.66	0.00	0.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	51.26	3.63	3.18	3.18	2.72	4.08	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	40.93	5.31	3.79	1.52	3.79	2.27	0.00	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	43.06	2.21	2.37	2.21	2.21	2.84	0.79	0.16	0.32	0.63
Fibroblast - Cardiac, donor4	11452-119A3	72.75	5.76	4.55	5.15	4.55	2.73	0.30	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	49.75	2.28	2.28	1.65	1.40	1.78	0.25	0.00	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	39.11	2.43	1.21	0.91	1.82	1.21	0.15	0.45	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.07	5.90	3.35	2.68	1.88	3.08	0.13	0.67	0.13	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.08	3.02	3.88	2.16	1.73	2.16	0.86	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	42.48	1.46	1.46	2.93	2.93	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	140.46	17.07	4.84	8.07	4.61	4.15	0.46	0.46	0.23	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	59.36	4.58	2.54	6.11	1.02	2.37	0.34	0.17	0.00	0.51
Fibroblast - Dermal, donor1	11269-116G9	34.98	2.35	1.17	1.88	0.47	0.23	0.23	0.70	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	35.85	0.94	1.42	0.94	1.89	0.47	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	41.71	3.87	1.57	1.69	0.12	1.81	0.48	0.12	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	35.16	1.81	2.03	1.58	0.90	1.47	0.23	0.11	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	31.75	4.36	1.05	2.27	1.57	1.74	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	24.53	2.27	1.95	2.76	1.14	2.11	0.00	0.00	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	61.22	2.50	0.83	2.29	0.42	1.25	0.00	0.83	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	79.91	9.43	6.03	4.72	1.83	3.14	2.62	0.79	0.52	2.10
Fibroblast - Gingival, donor2	11318-117D4	41.78	3.82	1.32	2.64	1.19	1.58	0.26	0.13	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	97.94	6.09	2.32	4.25	1.26	1.84	0.39	0.10	0.10	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	79.99	8.31	4.16	5.19	3.12	3.12	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	86.69	6.87	3.88	5.46	3.00	2.82	1.59	0.35	0.70	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	60.80	2.96	4.05	2.03	1.56	2.81	0.00	0.47	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	43.54	3.11	2.03	2.16	1.08	2.03	0.14	0.14	0.14	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	134.09	6.00	15.17	3.53	8.82	10.23	1.06	1.41	0.00	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.48	2.34	3.66	3.80	1.90	2.92	0.29	0.58	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	37.36	2.18	2.32	1.50	0.41	0.82	0.14	0.27	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	54.63	4.83	3.18	2.85	2.41	2.52	0.33	0.00	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.54	12.47	7.48	8.07	3.23	4.99	6.60	1.17	1.03	3.37
Fibroblast - Lung, donor1	11270-116H1	19.03	2.72	2.72	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	5.97	2.98	1.49	0.00	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	38.20	1.48	1.90	2.53	1.27	1.69	0.00	0.00	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	97.46	5.83	7.50	1.67	3.33	3.33	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	69.93	2.80	1.40	0.00	0.00	1.40	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	57.37	1.96	1.96	2.52	1.68	2.80	0.56	0.84	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	90.13	4.87	5.28	4.06	2.44	4.47	0.41	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	63.91	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	119.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.90	2.13	1.16	2.33	0.97	0.78	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.48	3.19	3.49	3.94	1.37	2.88	0.00	0.30	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	81.09	3.06	3.67	0.92	2.45	3.67	0.31	0.00	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	80.14	5.72	5.72	3.05	1.91	1.14	0.00	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	61.83	2.70	3.24	2.70	1.62	2.97	0.27	0.27	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	94.17	9.63	3.13	6.15	2.44	4.06	0.93	0.81	0.46	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.72	0.88	1.77	1.77	1.66	1.22	0.00	0.11	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	84.93	5.89	3.86	3.86	5.28	2.44	0.00	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	42.10	4.01	0.67	3.34	0.67	1.34	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.84	3.56	1.58	1.19	1.19	1.58	0.00	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	47.83	1.79	3.97	0.79	0.99	3.37	0.60	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	47.42	3.55	2.13	2.49	1.42	0.53	0.89	0.18	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.56	2.17	2.96	1.77	2.56	2.76	0.00	0.00	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	0.30	2.11	0.30	1.50	0.90	0.60	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	53.65	3.89	3.24	1.94	1.51	1.84	0.32	0.11	0.22	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	54.16	1.77	2.78	1.01	1.27	2.02	0.25	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	53.16	3.94	2.46	2.63	0.82	0.98	0.49	0.00	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	39.30	0.60	2.81	1.60	1.60	3.01	0.60	0.40	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	47.22	3.01	3.42	2.01	1.31	1.71	0.40	0.20	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	55.91	3.32	2.72	1.21	1.21	1.81	0.30	0.91	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	59.23	3.56	2.73	3.98	1.66	1.74	0.25	0.33	0.33	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	65.82	10.09	1.71	4.96	1.37	1.54	1.03	0.85	1.20	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.73	1.31	4.60	2.63	2.30	1.97	0.00	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	45.80	2.56	2.02	1.07	1.81	1.07	0.11	0.21	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	39.13	1.18	2.36	0.84	3.04	1.18	0.00	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	29.01	1.25	2.35	0.94	0.63	1.25	0.16	0.00	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	63.62	3.49	2.61	0.87	1.74	4.36	0.00	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	47.33	1.21	2.25	0.87	2.25	1.21	0.17	0.00	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	63.50	1.30	2.08	1.82	3.90	1.82	0.52	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	78.19	2.56	3.58	1.53	2.04	2.30	0.26	0.26	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	5.36	6.12	3.83	6.89	2.30	0.77	0.77	0.77	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	5.10	2.55	3.83	3.83	1.91	1.28	0.64	0.00	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.53	13.69	3.99	5.42	2.28	4.28	1.43	0.29	0.29	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	59.56	43.85	15.17	12.68	16.27	12.13	5.52	1.10	5.79	9.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	70.10	31.97	16.90	13.01	15.30	10.73	4.11	1.37	3.42	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	45.77	15.65	8.12	6.54	9.51	7.53	1.78	0.40	1.39	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.29	35.42	14.54	15.60	16.39	14.01	6.87	0.79	4.76	10.31
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	62.29	31.96	21.53	12.07	24.46	12.07	2.94	2.94	6.20	9.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.00	10.61	2.21	8.40	6.19	4.42	0.88	0.00	0.00	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.58	15.40	3.11	4.80	2.54	2.83	0.85	0.00	0.14	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.77	17.86	5.79	5.42	5.42	4.19	0.37	0.37	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.30	8.60	2.69	3.76	5.10	1.88	1.07	0.27	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.27	13.50	4.71	5.70	5.08	5.70	0.74	0.74	0.62	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.08	15.37	3.46	5.81	4.01	3.88	0.83	0.28	0.28	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.58	11.18	3.25	3.86	3.46	1.83	0.81	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.54	10.95	5.02	6.62	4.79	3.88	0.46	0.23	0.91	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.86	12.83	4.98	7.10	4.36	3.49	0.37	0.12	0.12	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.49	19.02	6.12	5.90	4.15	2.40	1.09	0.00	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.84	12.11	5.32	8.86	4.43	4.14	0.59	0.00	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	38.79	14.15	5.56	4.61	5.09	5.25	0.95	0.32	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.67	12.73	6.03	4.24	4.92	4.47	1.12	0.00	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	34.28	12.10	4.64	7.46	5.65	4.64	0.40	0.40	0.40	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.81	9.84	4.92	7.12	4.24	4.92	0.34	0.17	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.90	11.97	5.50	6.56	6.83	3.64	0.80	0.35	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.58	16.54	6.97	11.55	6.56	7.91	1.14	0.83	0.83	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.52	14.52	5.46	8.54	6.32	5.29	0.17	0.85	1.54	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.83	14.61	3.87	7.30	5.20	4.09	0.66	0.22	0.11	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.18	12.15	4.33	5.49	4.99	2.75	0.75	0.25	0.33	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.87	6.74	5.51	3.47	3.27	2.65	0.61	0.00	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.87	10.32	3.92	7.01	3.30	1.86	0.21	0.21	0.83	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.35	13.95	4.15	6.46	4.04	5.07	1.27	0.35	0.46	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.85	10.84	5.00	5.17	3.50	2.50	0.67	0.00	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	32.18	9.04	5.29	6.61	2.65	2.20	0.44	0.22	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	45.14	16.36	4.43	5.53	3.69	4.55	0.74	0.37	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.04	12.32	5.19	4.38	2.92	4.70	0.49	0.16	0.00	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.64	10.90	2.25	5.13	4.49	3.53	0.96	0.32	0.96	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	40.46	9.29	3.60	6.63	2.75	4.26	0.38	0.19	0.28	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.43	9.02	3.16	5.54	3.01	3.01	0.16	0.32	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.92	6.69	4.26	4.56	3.65	3.34	1.22	0.30	0.91	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.54	6.59	3.76	5.54	3.03	3.24	0.94	0.31	0.00	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	35.57	6.81	3.29	6.59	2.85	3.07	0.22	0.22	0.22	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.44	6.73	3.93	4.21	3.37	1.96	0.28	0.00	0.84	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	34.44	6.39	3.43	4.26	2.22	5.28	1.57	0.65	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.61	5.08	1.87	3.21	1.07	0.53	0.00	0.00	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.27	3.21	3.67	2.45	2.60	2.75	0.31	0.00	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.90	4.27	2.72	3.37	3.11	1.68	0.39	0.65	0.00	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.12	8.13	3.80	2.98	1.63	2.44	0.54	0.27	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.19	2.77	3.87	4.42	1.84	3.69	0.37	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.64	2.85	3.95	4.17	2.41	3.51	0.44	0.00	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	11.90	18.84	8.93	6.94	3.97	1.98	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	42.87	3.83	4.09	3.56	1.85	2.64	0.13	0.13	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	41.76	3.43	3.03	3.23	2.02	3.03	0.40	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	105.48	11.44	20.33	12.20	9.91	13.47	0.51	0.51	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.87	17.12	3.58	3.58	1.99	1.00	0.80	0.00	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	22.50	14.79	2.62	4.16	2.31	3.70	0.62	0.00	0.15	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.75	16.57	4.30	4.09	1.23	4.50	0.82	0.20	0.20	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	27.54	9.07	3.13	5.32	4.38	1.88	0.31	0.00	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.06	9.04	1.70	3.67	2.54	1.70	0.85	0.28	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.52	14.76	2.31	3.23	0.92	2.77	0.46	0.00	0.00	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	14.85	2.47	0.00	7.42	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	33.27	13.54	6.19	5.03	6.96	5.80	1.55	0.39	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	12.84	1.60	1.60	6.42	1.60	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	15.65	5.22	6.96	8.69	0.00	0.00	0.00	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.11	11.07	4.23	3.58	6.51	2.93	1.63	0.00	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.41	14.41	4.12	6.59	4.94	3.29	3.29	0.82	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	39.99	10.00	3.33	13.33	6.66	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.80	10.91	5.03	4.75	5.87	4.47	2.80	0.28	0.28	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.01	11.44	6.21	5.88	5.23	5.23	2.61	1.63	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	42.78	20.13	3.36	4.19	9.23	4.19	0.84	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.44	13.36	7.32	5.41	5.09	5.09	2.86	0.64	0.32	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.81	13.59	2.04	4.08	5.09	5.77	1.36	0.34	0.68	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	12.53	10.44	2.09	6.26	4.18	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.24	11.45	6.87	10.31	3.44	4.58	1.72	0.00	0.57	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.53	11.84	5.62	5.03	4.74	3.85	1.18	0.30	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	13.55	5.08	5.08	15.25	8.47	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	38.94	10.77	5.80	5.38	6.21	3.31	1.24	0.00	0.00	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.91	12.20	4.14	7.13	6.67	6.67	1.61	0.46	0.46	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	26.34	0.00	0.00	0.00	5.27	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.61	7.69	5.00	5.77	3.84	3.46	1.92	0.38	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.75	9.78	4.24	6.19	3.91	1.96	1.63	0.98	0.65	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.75	16.05	5.35	3.34	4.68	2.01	0.67	1.34	1.34	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	32.75	12.33	4.62	6.16	6.93	7.32	1.16	0.00	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	47.59	16.43	6.85	10.95	9.93	8.56	0.34	0.34	0.34	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	17.39	2.48	7.45	4.97	7.45	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.52	25.48	3.77	8.97	6.13	5.66	3.77	1.42	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.24	12.07	4.22	6.03	5.43	2.41	0.60	0.00	0.60	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	45.78	26.96	5.09	10.17	6.10	2.54	4.07	0.51	1.53	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.88	18.75	4.79	7.18	3.59	7.98	1.60	0.80	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	33.05	18.75	5.92	5.92	5.92	5.92	0.99	0.49	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	21.25	5.90	2.36	8.26	2.36	0.00	0.00	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	18.09	7.00	6.42	5.25	4.08	1.75	0.00	1.17	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.91	22.82	4.83	8.78	6.58	2.63	0.88	0.44	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	13.56	1.70	4.24	8.48	5.09	4.24	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.02	7.16	6.57	7.76	4.18	3.58	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	24.75	11.65	3.40	6.79	6.31	4.85	0.97	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	1.14	1.14	1.14	0.00	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	49.90	2.08	4.16	2.08	2.08	1.25	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	33.73	2.25	1.12	2.25	1.12	1.12	0.00	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.91	0.63	1.27	1.59	0.00	1.27	0.00	0.32	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	32.58	1.25	1.67	1.25	0.42	1.67	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.42	0.93	1.97	1.16	0.93	1.28	0.00	0.00	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.27	0.51	1.18	0.51	0.34	2.19	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.30	2.05	1.37	0.23	1.14	0.68	0.68	0.68	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.21	1.09	1.75	0.77	0.77	0.98	0.00	0.55	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.50	0.43	1.29	1.50	2.15	1.93	0.00	0.21	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.65	1.51	0.65	1.08	1.29	0.86	0.43	0.22	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	19.30	0.25	0.62	0.62	0.87	0.75	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.64	0.86	1.03	0.69	0.51	1.03	0.17	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.10	0.00	0.64	0.64	1.60	0.64	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	48.69	3.92	9.51	3.36	3.36	2.80	1.12	0.56	0.56	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	45.44	3.46	0.87	2.60	0.87	3.46	0.00	0.43	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	0.00	2.64	0.00	5.29	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	53.97	2.82	5.29	4.23	1.06	2.82	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	37.05	2.91	4.36	2.18	3.63	1.45	0.73	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	26.93	0.87	1.75	1.75	1.40	0.87	0.00	0.00	0.00	0.17
Hepatocyte, donor1	11523-119I2	79.90	2.42	12.11	1.21	3.63	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	113.12	3.23	6.46	2.15	11.85	3.23	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	97.55	2.45	9.82	4.29	6.75	3.68	0.00	0.00	0.00	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	47.65	1.31	3.92	1.31	0.00	5.22	0.65	3.92	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	54.88	2.97	8.04	3.67	6.47	2.27	0.70	0.70	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.85	1.51	1.65	2.20	1.78	0.82	0.14	0.00	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	6.37	0.00	3.18	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	0.00	1.38	0.00	0.00	6.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	0.00	0.00	5.01	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	2.56	2.56	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	0.00	4.57	0.00	0.00	9.14	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	0.00	3.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	1.67	0.00	0.00	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	0.00	10.89	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	35.73	0.00	1.32	0.00	0.00	3.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00	0.00	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	29.60	0.00	3.15	0.63	0.63	1.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	0.00	0.00	0.00	3.09	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	0.65	1.94	0.00	1.29	1.29	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	0.00	1.61	0.00	3.22	4.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.97	0.00	1.63	0.00	0.81	3.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	24.35	2.10	0.84	0.42	0.84	0.42	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.11	0.00	3.21	0.00	0.80	2.41	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	0.00	0.92	0.00	1.85	2.77	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.30	0.47	3.78	0.47	1.89	1.89	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	0.91	8.16	0.00	3.63	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	0.00	3.23	0.00	2.15	2.15	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	0.00	1.27	0.00	6.35	2.54	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	28.70	1.91	1.28	0.64	0.64	4.46	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	1.82	7.29	0.00	1.82	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.14	0.00	2.14	1.43	1.43	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	0.00	0.00	0.00	6.64	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.75	0.93	1.85	1.54	0.62	3.40	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	0.00	1.76	1.76	1.76	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	3.14	0.00	3.14	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	33.38	0.70	2.09	1.39	2.09	2.78	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	2.21	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	3.24	9.73	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	37.49	3.49	5.23	0.87	0.00	1.74	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	98.99	2.25	4.50	4.50	0.00	2.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	59.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	55.47	0.00	2.13	2.13	1.07	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	2.77	4.16	1.39	0.00	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	0.00	5.70	0.00	0.00	2.85	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	1.84	6.44	0.00	2.76	1.84	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	81.68	3.03	3.03	0.00	3.03	6.05	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	86.92	0.00	6.21	0.00	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	53.93	0.00	4.23	1.06	2.11	4.23	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	43.49	0.82	2.86	1.80	2.86	1.96	0.16	0.33	0.65	0.41
Keratinocyte - epidermal, donor2	11349-117G8	36.31	2.34	1.76	0.59	1.76	2.34	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	43.92	0.85	2.18	1.04	1.23	1.14	0.00	0.09	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	54.83	1.25	5.34	2.72	1.70	2.38	0.00	0.34	0.00	0.00
Keratocytes, donor1	11527-119I6	104.18	16.85	2.75	6.19	2.41	2.06	0.00	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	42.18	1.17	1.17	4.69	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	59.28	7.71	0.99	4.74	1.98	2.57	0.40	0.40	0.59	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	2.20	13.19	2.20	4.40	8.79	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	0.00	1.08	2.16	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.01	8.77	7.27	6.34	4.84	2.77	0.00	0.35	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	79.11	5.25	6.16	4.54	3.13	2.62	0.40	0.61	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	41.86	2.25	2.25	1.42	2.13	1.90	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.05	0.84	1.95	1.67	2.79	1.40	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.28	1.26	2.83	2.05	1.89	2.83	0.47	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.58	1.08	0.54	0.54	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.73	1.26	1.89	0.95	1.26	0.95	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.34	0.86	3.77	1.62	1.83	1.73	0.11	0.11	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.85	2.05	3.28	1.23	1.64	1.64	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.25	1.01	1.52	2.28	1.01	0.76	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.91	1.13	2.25	2.11	0.99	1.27	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	23.73	0.79	1.19	1.19	2.37	0.79	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.40	0.97	2.52	0.97	1.74	0.97	0.39	0.19	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.07	1.11	2.04	0.37	0.93	1.48	0.37	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	2.44	4.53	1.05	1.74	0.35	0.00	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.66	1.19	1.67	1.43	2.15	2.39	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	24.45	0.27	3.16	1.24	1.37	2.06	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.94	1.23	2.77	0.92	2.46	0.62	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.95	0.62	1.56	0.94	0.94	1.87	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.17	1.46	3.84	1.83	1.65	2.01	0.00	0.18	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	0.99	3.62	0.66	2.63	1.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.57	0.59	1.17	1.17	1.76	2.05	0.00	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	23.15	0.50	2.74	2.49	2.24	1.74	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.07	0.48	0.97	2.42	2.91	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	20.47	2.15	3.50	1.62	2.15	0.54	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.28	1.82	2.72	1.97	1.67	2.42	0.15	0.15	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.70	0.52	0.00	1.04	2.07	0.52	0.00	0.00	0.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.03	1.26	2.93	1.26	3.14	1.88	0.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.32	1.95	3.16	1.65	2.11	3.76	0.15	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	0.69	2.06	1.38	5.50	2.75	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.88	0.56	2.45	1.32	4.89	0.19	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.61	1.91	3.39	2.01	2.86	1.48	0.11	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.53	1.45	2.42	0.00	4.36	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.55	1.65	2.32	1.98	3.31	1.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.11	1.98	3.10	1.61	1.24	1.36	0.12	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.40	0.74	3.33	1.48	1.11	2.96	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.03	1.73	3.21	1.73	1.73	0.74	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.24	0.96	3.30	1.37	1.65	1.65	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.42	1.93	1.93	0.00	2.25	1.29	0.00	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.04	0.91	5.17	0.61	1.83	0.30	0.61	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.19	1.40	2.24	1.40	1.54	1.12	0.00	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.53	1.78	3.56	1.42	1.78	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	0.97	3.39	1.45	1.45	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.38	1.56	2.02	2.96	1.87	1.87	0.31	0.16	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	1.07	2.15	2.15	3.22	0.72	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.73	1.31	4.25	2.94	5.88	1.96	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	0.94	1.88	0.94	2.35	1.18	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	40.84	2.48	4.08	1.24	2.60	1.24	0.12	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.87	0.77	2.82	1.54	1.79	1.28	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.52	0.90	2.69	1.19	1.79	0.60	0.00	0.00	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	2.27	6.80	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.06	1.53	2.30	2.30	0.77	9.21	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.14	1.48	3.71	0.00	1.48	5.20	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	20.73	0.42	2.96	0.42	2.12	1.69	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.98	0.70	6.33	1.41	3.52	1.41	0.00	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	0.00	1.87	0.00	3.74	1.87	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	1.03	2.06	1.55	1.03	2.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	0.00	4.76	2.38	1.19	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.85	0.90	4.52	0.68	2.04	3.17	0.23	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	24.14	0.87	3.49	0.87	2.04	4.36	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.46	0.90	4.50	0.00	2.25	2.70	0.45	0.45	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.25	2.17	5.15	0.95	2.57	2.17	0.14	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.16	0.00	1.54	0.00	3.08	4.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.52	1.06	5.65	1.76	1.41	3.53	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	1.33	3.33	2.00	0.67	4.66	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	24.96	3.06	5.09	0.00	1.02	5.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.89	1.07	4.80	0.80	4.00	3.74	0.00	0.53	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	32.31	0.57	4.35	1.51	1.70	3.02	0.19	0.19	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.93	2.45	3.07	0.61	3.07	2.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	38.32	0.82	3.26	0.82	2.45	3.26	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.03	2.08	3.96	1.04	2.50	2.08	0.62	0.21	0.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.06	1.96	1.68	0.28	1.68	3.36	0.84	0.28	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	1.03	3.09	0.00	3.09	3.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.48	1.74	3.77	1.74	1.74	4.35	0.58	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.51	2.09	4.19	0.00	0.90	3.89	0.60	0.60	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.30	0.55	7.75	1.11	1.11	3.32	1.66	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	36.76	2.47	5.30	1.06	1.77	2.47	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.55	1.84	5.90	0.74	3.32	0.74	0.37	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	21.87	1.15	2.30	6.91	3.45	2.30	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.08	0.77	6.52	0.00	2.30	3.07	1.15	0.00	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	21.51	0.57	2.83	1.13	1.70	3.40	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	36.10	0.00	3.28	0.00	2.46	2.46	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	32.08	1.36	4.52	0.00	1.36	2.71	0.90	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	1.44	2.87	3.59	0.72	2.15	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	48.55	1.49	8.22	0.75	3.73	4.48	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.59	1.49	3.72	0.74	5.95	1.86	0.00	0.37	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	22.83	1.72	2.58	0.43	4.74	0.86	0.43	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	0.00	3.43	0.00	4.28	3.43	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.32	2.33	4.00	1.33	2.00	2.00	0.67	0.00	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.37	3.02	3.02	0.60	4.83	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	32.71	0.71	4.98	0.71	2.84	1.42	0.71	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.43	2.06	3.78	0.34	3.09	2.06	0.34	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.84	2.15	3.76	1.07	3.22	2.15	0.54	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	41.75	2.02	4.71	0.67	1.35	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	40.37	0.74	4.44	1.85	2.22	2.22	0.00	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	24.42	0.00	4.65	0.00	4.65	0.00	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	0.00	6.35	1.06	2.12	3.17	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	46.02	2.00	4.80	0.00	2.40	2.40	1.60	0.40	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.08	0.00	4.36	0.00	3.63	1.45	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.13	1.53	2.30	0.00	1.53	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	29.60	1.48	5.92	0.99	3.45	2.96	0.00	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	0.94	2.82	0.00	2.82	1.88	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	43.24	0.50	4.02	0.50	5.03	6.54	0.50	0.50	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.15	0.90	4.06	2.25	1.80	4.06	1.35	0.00	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	0.00	1.72	1.72	1.72	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	37.41	0.89	3.56	2.23	3.12	5.34	0.45	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	33.63	1.17	5.08	0.39	1.56	3.13	0.00	1.17	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.09	0.00	5.28	1.98	2.64	1.32	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.77	0.52	5.19	1.56	3.11	4.15	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	37.63	2.19	3.50	0.44	3.06	3.06	0.44	1.31	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.33	1.68	4.47	0.00	2.80	1.12	1.12	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.86	2.65	4.86	0.44	2.21	1.77	0.44	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.56	1.54	3.47	0.39	4.63	5.79	0.00	0.39	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.89	2.03	4.05	0.51	1.52	3.04	0.00	0.00	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	42.78	4.81	5.77	0.96	4.33	2.40	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.19	2.78	5.96	0.00	1.19	1.99	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	3.04	3.65	0.00	1.82	2.43	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	2.77	1.38	1.38	2.08	1.38	0.00	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.96	0.76	6.46	1.90	2.66	2.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	2.58	4.65	1.03	3.10	2.07	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	1.81	3.02	0.00	2.42	0.60	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.71	2.22	3.17	0.32	3.17	3.49	0.00	0.95	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	2.67	5.86	0.53	2.67	5.33	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.61	1.72	5.75	0.00	4.02	2.87	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.45	2.06	6.69	1.03	4.11	2.57	0.00	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	2.83	2.83	1.41	0.71	2.12	1.41	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	34.62	3.40	3.40	1.13	1.70	2.27	0.00	0.57	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	36.19	0.42	3.74	1.25	4.16	4.58	1.66	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	2.35	1.57	2.35	3.13	1.57	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	38.00	2.09	5.43	1.67	2.09	2.51	0.00	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.06	0.93	4.18	0.46	5.58	2.79	0.00	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.10	0.67	2.68	3.35	1.34	2.01	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	47.05	1.60	6.95	1.07	3.74	3.74	0.00	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.58	1.21	5.25	0.81	6.87	3.64	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	1.84	3.67	0.92	1.84	4.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	52.46	2.67	3.56	1.78	5.33	1.78	0.00	1.78	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	40.46	1.71	5.13	0.00	5.13	5.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	34.51	3.83	3.83	1.53	8.44	2.30	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	49.25	4.92	3.83	2.74	1.09	1.09	0.55	0.55	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.97	4.01	8.02	1.78	3.56	1.78	0.00	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	46.27	4.16	4.68	2.34	3.90	1.04	1.30	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	46.42	3.98	3.98	2.65	4.64	3.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	2.08	4.16	2.08	0.00	4.16	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	47.63	0.68	0.46	1.14	0.46	2.28	0.00	0.23	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	23.86	0.73	3.49	0.00	1.47	1.10	0.18	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	43.91	0.52	2.88	0.26	0.79	1.97	0.13	0.39	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.33	0.53	0.00	0.53	0.53	1.06	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	38.82	1.74	2.38	0.48	1.74	1.11	0.16	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	31.83	1.25	1.53	0.83	2.22	0.83	0.28	0.00	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	55.10	3.19	1.49	2.29	1.10	2.59	0.20	0.10	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	39.96	1.74	0.58	0.87	0.58	1.16	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	25.19	0.75	0.50	0.25	0.50	0.75	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	82.71	4.75	4.07	5.42	2.71	3.39	1.36	0.68	0.00	0.68
Mast cell, donor1	11563-120D6	94.52	5.84	3.46	6.70	1.84	4.33	3.35	0.54	0.54	2.70
Mast cell, donor2	11565-120D8	116.79	5.35	5.94	5.65	2.08	2.67	3.57	0.00	0.30	2.97
Mast cell, donor3	11566-120D9	141.15	13.51	7.65	8.55	4.05	3.38	6.53	0.45	0.68	4.05
Mast cell, donor4	11567-120E1	110.27	9.75	4.43	7.98	2.48	3.19	5.85	0.89	0.35	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	68.42	4.99	3.11	4.21	1.00	2.44	1.11	0.11	0.22	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	67.12	13.42	2.33	7.59	3.50	1.17	1.17	0.00	0.00	8.76
Mast cell, expanded, donor5	11939-126A4	53.92	4.59	1.15	3.67	0.69	1.95	2.29	0.34	0.46	3.10
Mast cell, expanded, donor8	11941-126A6	86.19	4.85	4.02	7.53	1.51	4.85	3.01	0.33	1.00	3.18
Melanocyte - dark, donor1	11502-119F8	40.89	0.90	3.08	1.59	1.59	0.60	0.00	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	29.07	2.42	1.73	1.73	2.08	0.35	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	37.09	1.81	1.52	1.38	1.09	1.01	0.14	0.00	0.07	0.07
Melanocyte - light, donor1	11274-116H5	44.43	6.58	2.12	4.23	1.41	1.65	3.06	0.24	0.71	0.24
Melanocyte - light, donor2	11351-117H1	19.11	2.05	3.41	3.41	0.00	0.00	1.36	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	38.16	3.47	1.73	0.87	1.73	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	32.49	2.29	1.35	2.81	0.62	0.94	0.21	0.00	0.31	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	23.40	0.54	0.81	2.15	0.54	1.88	0.00	0.27	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	51.16	1.87	2.95	4.02	4.29	2.41	1.34	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	49.00	4.09	3.23	1.61	1.61	0.99	0.25	0.37	0.00	0.12
Meningeal Cells, donor2	11573-120E7	58.54	3.08	5.28	6.60	0.44	3.96	0.88	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	32.11	1.22	1.39	1.47	1.14	1.30	0.16	0.08	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.09	1.14	2.28	1.43	0.57	2.85	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.96	3.32	3.02	2.92	3.12	2.31	0.50	0.20	0.10	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	32.85	2.63	1.31	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	0.72	0.00	0.00	0.00	0.72	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.75	4.45	4.24	2.75	1.27	1.91	0.42	0.42	0.85	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.71	4.02	3.02	2.01	4.02	0.50	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	40.21	2.42	2.64	1.32	1.32	1.32	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	41.64	2.19	2.92	0.73	0.73	0.73	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	37.85	2.05	1.23	0.82	1.64	1.64	0.00	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	42.24	2.91	1.80	1.52	0.42	1.39	0.14	0.28	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	43.86	2.60	3.35	3.72	1.12	1.12	0.37	0.00	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	52.50	8.95	2.76	6.45	1.32	0.92	0.00	0.13	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.30	3.86	2.08	3.56	1.19	1.48	0.30	0.30	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	32.70	4.67	0.00	2.34	0.00	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	37.14	2.56	0.64	1.92	0.64	1.92	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.75	0.71	0.35	1.06	0.00	0.35	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.85	5.94	2.19	3.13	0.00	1.25	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.12	2.18	0.00	2.18	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	60.73	3.98	4.51	1.86	5.57	1.86	1.86	0.00	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	82.08	2.50	4.00	1.00	4.00	3.00	0.50	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	83.83	3.25	4.84	1.81	4.12	2.96	0.51	0.36	0.36	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	147.19	2.70	4.05	1.35	10.80	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.39	0.99	2.46	0.25	0.99	2.71	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	24.73	1.18	4.42	0.88	2.06	1.18	0.59	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	3.46	3.46	0.00	3.46	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.83	0.31	1.86	0.00	0.93	1.55	0.31	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.08	0.41	2.49	0.83	0.62	1.24	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	0.00	2.32	0.00	2.32	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.04	1.00	3.00	1.50	1.00	1.75	0.50	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.05	0.47	7.45	0.93	0.93	1.40	0.00	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.50	1.02	2.24	0.81	1.02	1.42	0.20	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	0.79	0.40	1.19	1.19	0.40	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	8.55	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	0.00	0.88	0.00	0.88	1.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.96	0.76	0.38	0.00	1.14	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	65.80	2.63	1.32	2.63	1.32	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.92	0.42	2.55	0.42	0.42	1.27	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	2.76	1.84	0.00	2.76	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.96	0.89	0.60	0.00	0.60	1.19	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	0.00	5.03	0.00	6.71	3.35	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	27.60	1.25	1.51	0.00	0.75	1.51	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.25	0.95	2.38	1.66	0.71	1.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	56.39	1.66	2.76	0.55	0.55	0.55	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.31	0.69	1.38	0.23	1.15	2.53	0.00	0.00	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.24	1.05	2.10	1.05	0.42	1.47	0.00	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	35.47	1.22	2.65	0.61	2.24	2.04	0.20	0.61	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.60	1.07	1.29	0.21	1.07	0.43	0.43	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.90	0.44	2.45	1.11	2.22	1.56	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	34.60	0.44	1.10	0.88	2.41	0.66	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.81	1.01	3.04	1.01	2.03	2.03	0.51	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	3.31	1.66	0.00	1.66	0.00	0.00	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.13	1.90	2.45	0.82	2.99	0.82	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.70	0.00	1.18	0.29	0.88	0.88	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	38.16	3.27	2.18	0.00	5.45	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.99	1.44	0.48	0.48	0.00	0.48	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.41	0.80	1.20	2.00	1.20	0.40	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	54.85	1.37	1.37	1.37	4.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	26.03	1.00	2.00	0.00	1.00	0.50	0.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	2.04	2.04	2.04	8.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	33.28	0.00	0.00	0.00	0.00	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	1.10	2.21	0.00	4.41	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	70.44	0.64	6.40	0.64	3.20	3.84	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.76	1.24	2.23	0.99	0.74	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	27.14	0.70	0.00	0.70	2.09	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	0.00	6.63	4.42	11.05	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.20	0.68	1.37	0.68	2.39	1.71	0.00	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	1.31	1.75	0.88	1.31	1.75	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	90.19	4.26	3.20	1.78	3.91	2.13	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	36.19	1.40	1.68	0.84	0.84	0.84	0.56	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.51	0.83	2.49	0.42	0.83	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	89.16	2.33	4.08	2.33	5.24	1.17	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	53.70	2.11	1.81	0.90	0.60	1.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.38	1.67	0.42	0.00	1.67	0.83	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	48.02	1.85	1.85	0.92	0.00	2.77	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	32.44	2.28	1.71	0.00	2.28	1.14	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	61.63	1.52	3.18	2.07	2.07	1.93	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	35.50	2.07	1.04	1.04	0.00	1.55	0.26	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	40.32	1.29	2.57	0.43	2.14	1.72	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	73.68	0.64	0.64	1.91	5.08	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	58.72	1.33	2.40	1.33	2.14	3.74	0.00	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	52.68	1.50	3.59	2.10	1.20	2.10	1.20	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	69.78	1.70	2.26	2.68	2.12	2.26	0.85	0.42	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	35.04	2.87	0.96	2.23	1.91	1.59	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.59	3.32	1.77	1.11	0.88	2.43	0.66	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	76.22	2.65	4.17	1.52	2.65	1.52	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.87	0.85	1.70	0.85	0.85	1.70	0.57	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	34.41	1.47	1.72	1.23	1.47	1.47	0.49	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	89.93	5.21	3.26	2.61	3.26	1.96	1.30	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	60.86	1.47	3.23	2.06	2.94	1.76	0.88	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	48.15	2.59	5.48	1.44	2.88	2.02	1.15	0.86	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	94.38	4.53	4.95	2.47	4.95	4.53	1.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	64.92	2.38	4.47	1.49	2.98	2.98	1.19	0.30	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	0.00	0.00	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	43.70	0.33	0.66	0.99	0.66	0.99	0.33	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	0.00	1.05	0.00	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.11	1.19	0.99	0.20	0.79	1.38	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	61.47	3.73	1.86	0.93	0.00	1.86	3.73	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.55	2.25	2.25	0.75	0.75	2.25	0.75	0.00	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.77	0.53	1.07	0.27	0.27	1.07	0.80	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.41	0.34	0.34	0.23	0.34	0.45	0.11	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	0.74	2.21	0.00	0.74	0.00	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	38.11	0.37	1.10	0.73	0.37	1.83	0.00	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	3.11	0.00	0.00	0.00	4.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	23.52	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	0.00	2.02	0.00	0.00	1.01	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.50	0.00	0.84	0.42	0.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	0.00	0.00	0.00	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	6.52	0.00	0.00	3.26	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	44.60	1.94	3.23	3.02	1.29	2.15	0.22	0.22	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.58	5.75	6.27	5.23	3.14	2.09	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	2.00	2.67	2.67	3.34	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.98	2.50	9.60	1.25	2.92	2.50	0.83	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	35.18	1.52	5.51	1.71	4.56	3.80	0.76	0.19	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	137.24	12.77	12.77	6.38	7.98	7.98	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	2.04	3.40	0.00	2.72	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	99.23	3.68	1.84	3.68	1.84	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	1.67	3.35	0.84	2.51	3.35	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	32.31	1.39	3.49	1.39	3.72	1.39	0.46	0.23	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	50.26	4.59	4.05	2.43	2.97	3.78	0.54	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	53.82	4.63	3.78	4.63	2.52	4.84	0.84	0.63	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	0.00	0.00	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.79	2.48	0.99	1.49	1.49	1.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.71	1.62	2.71	3.79	2.17	2.98	1.62	0.54	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.24	1.81	3.63	1.13	1.13	2.04	0.91	0.23	0.45	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	51.28	3.92	4.25	2.45	1.96	2.94	0.98	0.16	0.00	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	55.04	4.56	3.83	2.73	2.37	5.29	1.09	0.18	0.00	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.01	4.24	3.71	0.53	2.65	4.24	1.06	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	39.62	4.80	3.60	3.00	1.80	1.20	1.20	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.63	4.27	4.59	3.61	0.98	2.95	0.33	0.98	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	37.57	1.79	3.42	1.46	2.93	2.60	0.65	0.49	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	97.01	6.35	9.35	4.76	4.23	3.88	1.41	0.18	0.35	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	37.27	4.22	3.52	1.41	1.41	1.41	0.70	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.42	3.68	2.30	2.30	1.38	1.84	1.38	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.45	3.53	4.50	2.25	2.25	4.18	0.96	0.00	0.32	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	47.59	3.10	6.21	3.45	4.14	3.79	1.38	1.03	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	313.53	5.06	17.70	25.28	5.06	12.64	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	80.65	7.13	7.57	4.23	4.01	4.68	0.00	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.52	4.23	3.81	2.12	4.23	2.12	0.85	0.00	0.42	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	29.19	3.32	3.56	2.37	1.90	1.19	1.42	0.71	0.24	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	31.34	5.58	6.44	3.00	2.58	3.43	0.86	0.00	0.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	0.00	0.00	18.06	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	55.31	7.00	5.00	4.67	3.00	3.00	1.33	0.67	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	64.92	9.92	10.82	4.96	8.12	6.76	0.00	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.98	3.97	3.17	2.38	2.78	1.59	0.79	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	48.29	4.64	1.86	2.79	0.93	3.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	32.16	9.46	2.65	1.89	2.65	0.00	1.89	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	48.23	5.87	6.84	1.63	4.89	1.63	1.30	0.33	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	61.01	6.97	5.23	3.05	3.92	3.92	0.87	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	85.03	4.52	9.05	6.78	9.05	5.88	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	4.41	2.65	0.00	6.17	1.76	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	34.57	3.99	1.99	1.33	2.66	0.66	1.33	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	39.19	10.91	2.98	1.98	4.96	3.97	1.98	0.00	0.50	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	51.68	9.95	8.42	0.38	8.80	5.74	1.15	0.77	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	37.20	2.12	3.63	2.72	1.51	0.91	0.30	0.60	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	55.26	7.51	8.84	3.32	4.20	3.09	1.11	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	45.40	4.74	4.74	2.03	2.03	5.42	2.71	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	97.08	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	39.63	9.75	4.88	0.00	2.44	1.22	1.83	0.00	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.60	6.92	4.41	1.57	5.67	0.94	1.26	0.31	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	41.16	2.72	7.87	2.12	4.24	3.33	1.51	0.61	0.00	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	5.54	4.75	0.79	4.75	1.58	1.58	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	81.62	17.00	5.67	6.80	5.67	1.13	1.13	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	0.00	0.00	10.12	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	33.91	1.37	1.74	1.37	1.86	1.24	0.25	0.25	0.00	0.37
Myoblast, donor2	11322-117D8	55.62	3.07	4.22	0.58	1.73	2.49	0.00	0.00	0.19	0.19
Myoblast, donor3	11398-118D3	46.41	0.84	3.03	1.51	2.52	2.02	0.67	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	36.92	1.61	3.36	0.15	1.75	3.65	0.44	0.73	0.00	0.29
Natural Killer Cells, donor1	11230-116C6	106.09	2.46	10.15	3.69	4.92	4.92	2.15	2.15	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	109.16	1.51	7.84	3.32	3.62	3.62	1.51	0.90	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	133.07	3.31	8.47	2.76	3.50	7.55	0.92	1.66	0.00	2.76
Neural stem cells, donor1	11275-116H6	95.45	17.42	20.32	15.61	16.33	8.35	2.90	0.36	0.73	2.18
Neural stem cells, donor2	11352-117H2	69.32	19.26	15.41	9.63	19.26	15.41	3.85	0.00	0.00	1.93
Neurons, donor1	11494-119E9	51.21	15.93	7.97	1.14	9.10	11.38	2.28	0.00	0.00	1.14
Neurons, donor2	11574-120E8	51.52	6.38	6.38	4.62	3.74	4.84	0.22	0.88	0.22	0.22
Neurons, donor3	11655-122E8	41.11	26.31	10.69	6.58	12.33	10.69	2.47	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	411.11	2.78	22.27	20.42	13.92	6.50	1.86	2.78	0.00	5.57
Neutrophils, donor2	11314-117C9	344.97	5.80	20.29	20.29	2.90	5.80	5.80	2.90	0.00	5.80
Neutrophils, donor3	11390-118C4	681.70	25.04	46.42	43.98	28.10	10.38	3.05	1.83	3.67	10.38
Nucleus Pulposus Cell, donor1	11252-116F1	55.81	4.27	2.73	7.36	0.83	2.61	0.12	0.24	0.24	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	44.28	1.63	1.63	2.93	0.65	3.26	0.33	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	38.51	4.81	1.00	3.41	0.00	0.80	0.00	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	47.08	4.27	2.48	2.06	0.83	2.20	0.41	0.55	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	40.24	3.04	2.61	2.61	1.88	2.46	0.58	0.58	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	46.54	2.50	2.72	2.04	1.70	1.82	0.11	0.11	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	61.46	4.48	3.99	3.99	2.34	3.99	0.68	0.10	0.00	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	57.17	2.41	1.20	0.60	3.01	3.61	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	54.66	6.17	4.04	3.62	2.55	2.34	3.40	0.21	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	52.58	8.00	3.43	5.72	1.14	0.00	2.29	0.00	0.00	5.72
Osteoblast - differentiated, donor3	11425-118G3	54.62	9.93	0.00	3.10	1.86	1.86	0.62	0.00	0.00	2.48
Osteoblast, donor1	11277-116H8	41.43	6.84	2.54	2.15	1.17	1.76	0.20	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	30.20	2.11	2.81	0.70	2.81	4.21	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	41.59	3.20	2.31	2.31	1.96	3.20	0.18	0.18	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	42.79	2.19	2.44	2.86	0.59	1.94	0.25	0.08	0.51	0.51
Pericytes, donor1	11491-119E6	54.85	4.56	3.34	3.67	1.11	2.78	0.11	0.33	0.33	0.22
Pericytes, donor2	11571-120E5	58.18	6.11	5.66	4.98	2.26	4.98	0.45	1.13	0.00	0.91
Pericytes, donor3	11652-122E5	53.51	3.46	3.26	3.26	2.85	1.83	0.20	0.00	0.00	0.61
Perineurial Cells, donor1	11499-119F5	44.19	3.84	2.60	2.83	0.90	2.94	0.45	0.00	0.00	0.00
Perineurial Cells, donor2	11579-120F4	42.05	1.75	3.13	2.94	1.66	1.84	0.18	0.09	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	131.64	1.91	8.61	3.19	0.96	6.69	1.91	3.19	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	112.15	3.67	3.43	2.94	3.18	5.14	0.98	1.22	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	122.43	3.11	8.41	2.98	3.49	5.05	1.29	2.07	0.26	1.04
Placental Epithelial Cells, donor1	11278-116H9	25.59	1.20	1.43	1.43	3.35	0.96	0.24	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	25.50	2.22	0.00	2.22	0.00	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	40.84	0.98	1.96	1.96	1.37	1.96	0.39	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.59	1.58	2.22	0.63	1.58	0.63	0.00	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	33.39	3.19	1.69	2.06	2.44	1.13	0.19	0.00	1.13	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	45.03	0.65	1.04	1.04	1.70	1.31	0.26	0.13	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	53.36	3.15	3.60	2.03	1.58	1.58	0.68	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	55.52	5.33	3.41	2.02	1.60	2.34	1.28	0.21	0.64	0.85
Preadipocyte - omental, donor2	11329-117E6	49.32	2.62	3.06	1.31	3.49	1.31	0.44	0.00	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	75.21	4.44	4.58	3.29	3.29	3.15	0.57	0.29	0.72	1.15
Preadipocyte - perirenal, donor1	11469-119C2	44.29	5.91	2.95	2.95	0.00	1.97	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	36.85	2.76	0.92	0.61	2.15	2.15	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	43.74	2.48	1.95	2.12	1.77	1.77	0.00	0.35	0.00	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	49.89	4.43	4.26	3.24	2.55	1.53	0.85	0.51	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	42.10	2.24	2.70	2.33	1.49	1.77	0.65	0.00	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	50.16	4.60	3.22	2.76	0.46	2.30	0.00	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	32.50	2.61	1.57	2.19	1.04	1.04	0.42	0.00	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	34.85	5.28	5.73	4.53	5.13	2.11	1.06	0.00	1.66	0.75
Prostate Epithelial Cells, donor2	11331-117E8	43.47	2.44	4.74	4.06	4.33	2.71	0.00	0.00	0.54	0.81
Prostate Epithelial Cells, donor3	11404-118D9	84.57	2.88	4.78	4.23	3.74	2.82	0.92	0.24	1.29	1.04
Prostate Stromal Cells, donor1	11254-116F3	42.60	3.87	2.73	3.64	1.25	1.03	0.23	0.23	0.23	0.57
Prostate Stromal Cells, donor2	11332-117E9	52.18	5.56	2.33	3.59	1.79	1.79	0.36	0.18	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	45.78	7.72	3.44	6.99	1.77	3.34	1.04	0.21	0.63	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	67.52	5.84	4.01	2.55	0.73	3.65	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.56	1.94	2.63	2.29	1.59	1.59	0.14	0.07	0.07	0.28
Renal Epithelial Cells, donor1	11517-119H5	50.22	1.52	3.55	3.04	2.03	2.54	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	43.39	0.71	2.85	2.85	1.42	1.42	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	43.19	3.07	2.54	2.75	0.64	1.80	0.21	0.32	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.28	4.09	3.40	2.04	1.36	2.04	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	30.46	1.62	2.56	1.62	1.21	0.94	0.00	0.27	0.13	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.40	1.55	2.22	0.67	3.33	1.78	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	35.93	1.33	4.66	0.67	2.66	1.33	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	43.36	3.08	3.74	3.52	2.20	3.30	0.22	0.22	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	40.75	1.88	3.76	3.76	2.51	5.64	0.00	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	54.37	1.94	4.99	4.44	2.77	3.33	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.36	2.95	3.22	2.15	0.54	1.34	0.54	0.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	42.17	4.64	2.53	2.11	3.37	2.53	0.00	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	42.04	3.66	3.47	0.77	1.35	2.70	0.58	0.58	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.04	2.33	2.07	0.52	0.78	1.04	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	46.05	3.70	4.55	3.41	1.14	2.84	0.28	0.00	0.28	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	29.84	3.09	3.09	3.09	2.06	3.09	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.60	2.76	1.25	3.26	2.26	1.25	0.50	0.00	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	104.24	3.88	6.82	6.41	4.01	4.94	0.94	0.53	0.53	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	49.14	6.25	5.36	1.79	7.15	4.47	0.89	0.00	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.57	2.75	2.75	3.85	3.85	2.75	1.65	0.00	0.00	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	56.85	4.64	4.06	1.16	7.54	2.90	2.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	49.02	2.60	4.42	2.86	3.12	3.38	0.26	0.65	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	50.75	1.99	4.97	2.09	2.98	4.17	0.00	0.99	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	53.20	1.67	5.02	1.34	3.79	4.35	0.22	0.56	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.38	1.24	3.97	2.48	1.74	3.60	0.12	0.50	0.25	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	51.16	2.21	5.13	2.21	4.66	5.13	0.00	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	64.02	2.31	8.55	2.31	4.62	3.93	0.23	0.69	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.75	1.51	5.75	1.51	3.15	4.11	0.27	0.82	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.53	1.51	4.69	2.72	3.48	5.75	0.15	0.15	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	57.70	1.25	5.38	1.25	5.02	4.84	0.18	0.72	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.53	3.01	5.45	2.30	3.16	5.02	0.29	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	47.43	2.15	4.83	1.72	3.65	5.04	0.21	0.21	0.21	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.94	2.21	4.87	1.99	3.54	6.42	0.22	0.89	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	63.85	2.10	6.50	1.53	3.63	4.40	0.38	0.38	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	61.86	1.58	5.12	2.61	3.17	5.03	0.28	0.09	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	51.30	1.13	7.33	3.57	3.76	3.01	0.19	0.00	0.56	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	75.91	3.72	7.03	2.39	5.84	3.58	0.00	0.93	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.10	3.11	7.98	3.41	4.28	6.04	0.39	0.39	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.39	2.67	4.77	2.29	4.01	5.16	0.00	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.83	2.46	5.02	2.24	3.10	4.16	0.53	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	56.06	2.24	4.48	1.96	3.92	4.77	0.28	0.00	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.96	1.54	6.15	2.22	2.91	5.47	0.17	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.99	2.01	4.74	2.92	3.83	5.65	0.36	0.55	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	54.45	2.45	5.40	1.96	2.21	4.66	0.12	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	58.97	2.42	5.64	3.22	3.36	6.58	0.13	0.67	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.64	1.89	4.95	1.65	1.65	4.95	0.00	0.47	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.40	1.59	5.36	1.98	3.77	6.94	0.00	0.79	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	55.89	2.34	6.78	1.17	4.44	5.61	0.23	0.47	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	44.17	3.11	5.18	2.70	2.49	4.77	0.41	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.23	2.43	3.54	1.55	2.65	2.43	0.00	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.76	3.13	7.10	2.51	3.97	4.80	0.00	0.63	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	55.99	2.42	4.98	1.88	4.17	3.50	0.27	0.54	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	69.99	3.24	6.47	1.87	4.09	7.66	0.17	1.53	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.66	2.31	6.36	2.89	3.47	7.71	0.19	0.39	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	49.86	1.55	4.99	1.03	1.38	3.61	0.69	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	57.61	2.47	5.90	1.65	4.25	7.54	0.00	0.55	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.01	1.81	7.39	2.63	3.12	5.09	0.00	0.49	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	58.97	2.39	5.97	1.19	2.56	4.26	0.17	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	53.26	2.07	3.55	2.96	2.66	7.10	0.15	0.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	69.04	1.60	5.33	2.13	5.33	5.60	0.00	1.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	80.06	7.88	5.81	5.95	4.98	4.42	0.55	0.69	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.57	1.67	2.62	2.38	2.62	5.24	0.24	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	85.05	2.42	11.08	4.03	5.24	7.46	0.60	0.40	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	52.17	3.77	3.01	3.20	2.83	3.86	0.28	0.19	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	66.38	6.29	6.29	5.94	3.49	5.24	0.70	0.35	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	64.37	6.04	6.65	5.44	5.74	6.35	0.30	0.60	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.73	2.33	4.16	2.69	1.47	3.30	0.73	0.37	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	127.50	8.01	14.56	7.71	10.92	9.61	0.58	1.60	0.44	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	63.28	1.22	7.30	5.48	4.87	4.26	0.61	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.31	0.90	3.32	3.32	1.21	0.30	0.00	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	66.05	4.98	7.69	6.33	4.98	4.98	0.45	0.68	0.90	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	83.57	4.19	9.29	5.09	6.59	6.59	0.90	0.30	0.30	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.95	6.85	7.32	9.56	3.42	4.25	1.06	0.71	1.18	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	60.19	8.11	8.96	7.90	5.34	5.55	4.06	0.43	1.49	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	70.92	7.81	4.81	5.41	7.81	4.21	4.21	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	42.50	3.01	3.01	2.44	1.32	1.13	0.00	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	17.01	0.00	0.00	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	28.26	1.31	1.75	1.53	0.88	1.10	0.44	0.00	0.22	0.22
Sebocyte, donor1	11220-116B5	97.50	1.10	6.57	3.29	8.22	3.29	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	73.99	3.22	4.14	2.30	0.46	0.00	0.92	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	82.45	1.65	5.36	2.89	2.89	1.65	0.41	0.41	0.41	1.03
Sertoli Cells, donor1	11255-116F4	61.29	3.31	1.66	11.60	6.63	1.66	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	76.26	8.47	5.65	5.65	0.00	0.00	11.30	2.82	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	58.77	7.13	5.28	6.60	2.99	4.66	1.14	0.18	1.58	1.14
Skeletal Muscle Cells, donor2	11358-117H8	54.21	7.23	0.00	5.78	1.45	2.17	0.00	0.00	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	42.64	3.34	3.34	2.51	1.67	2.51	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	24.04	2.51	2.04	1.57	1.10	1.73	0.16	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	22.59	2.53	0.45	0.89	0.74	0.59	0.15	0.15	0.00	0.59
Skeletal Muscle Cells, donor6	11459-119B1	31.40	2.31	1.54	1.39	1.08	1.85	0.00	0.00	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.00	2.77	1.26	3.53	1.13	2.02	0.13	0.13	0.00	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	44.09	2.43	2.71	3.28	0.71	2.57	0.14	0.29	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	43.16	4.17	2.28	3.27	2.58	1.49	0.20	0.10	0.00	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	52.57	3.71	5.64	4.38	3.96	3.62	0.93	0.42	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	62.24	6.51	4.34	8.69	2.17	1.45	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.92	2.06	3.30	2.20	1.65	2.06	0.14	0.14	0.28	0.41
Skin - palm, donor1	10286-104F7	99.39	2.69	2.69	2.69	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.52	1.15	1.87	0.14	1.44	1.01	0.00	0.43	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	68.70	0.00	13.09	0.00	9.00	7.36	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.15	0.91	1.56	0.65	0.91	2.21	0.26	0.00	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	38.92	2.09	1.95	3.48	2.50	1.67	0.70	0.00	1.11	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	86.64	3.09	5.34	4.08	4.22	2.67	0.84	0.42	0.00	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	110.59	2.33	4.65	2.11	5.29	6.98	0.00	0.63	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	131.31	4.57	7.87	5.40	5.40	3.45	0.60	0.30	0.60	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	53.39	4.01	3.70	4.63	2.16	0.62	1.23	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	47.36	3.78	2.45	2.67	2.00	1.78	0.22	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	49.97	1.18	1.76	4.70	0.59	1.18	0.00	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	73.59	2.21	2.65	2.87	2.21	2.21	0.44	0.22	0.22	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	40.17	2.36	0.39	2.36	3.54	0.79	0.79	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.22	5.41	1.55	1.55	2.32	0.77	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	2.00	3.00	6.00	0.00	4.00	0.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	40.85	4.13	1.86	3.06	1.73	1.33	0.13	0.13	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	55.19	4.21	1.99	3.55	1.11	0.89	0.44	0.44	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	59.92	9.47	2.56	3.84	2.05	1.54	1.41	0.13	0.00	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	2.93	1.95	2.28	0.33	1.30	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	50.50	2.36	3.54	1.48	0.59	2.36	0.30	0.00	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	56.23	2.14	3.13	1.99	2.14	1.99	0.43	0.43	0.57	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	49.13	2.11	1.95	1.95	1.30	1.79	0.16	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	58.76	5.48	2.44	6.09	0.61	2.74	0.30	0.30	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.94	3.03	3.54	3.28	2.53	2.02	0.76	0.51	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	0.00	0.00	0.00	0.00	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	28.13	3.34	0.95	2.86	0.00	0.48	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.07	1.92	1.62	3.10	1.03	0.44	0.15	0.29	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	43.05	2.80	2.58	2.58	1.08	1.51	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.78	2.83	2.83	3.04	1.57	1.47	0.10	0.21	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.35	1.70	2.17	2.32	3.71	1.70	0.46	0.31	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	60.36	3.23	1.08	1.08	3.23	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.17	2.99	2.09	1.20	2.69	1.79	0.30	0.90	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	49.84	3.76	1.71	2.39	0.68	1.71	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.12	2.83	1.49	5.50	0.71	1.88	0.16	0.16	0.08	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.67	13.89	4.53	9.46	4.63	3.52	3.93	0.50	2.31	3.22
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	76.46	5.46	3.41	2.73	1.37	2.28	0.68	0.46	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	32.00	4.23	3.02	0.60	0.60	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	27.82	7.42	1.85	5.03	1.32	1.06	0.00	0.26	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	45.01	6.52	3.06	3.86	1.07	2.26	0.40	0.27	0.53	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	72.50	6.64	6.14	5.38	2.88	3.13	1.38	0.38	1.25	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.06	1.78	1.78	3.55	0.51	1.27	0.51	0.25	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	44.93	3.32	2.56	4.67	1.06	0.90	0.45	0.15	0.00	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	36.01	1.50	1.50	0.75	4.50	2.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	547.90	15.51	0.00	41.35	7.75	6.46	18.09	1.29	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	53.95	3.26	3.26	1.40	2.33	3.72	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.93	3.53	3.03	3.03	3.03	1.01	0.50	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	48.58	6.89	2.82	1.57	1.88	1.25	1.57	0.31	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	32.15	1.47	1.47	2.36	0.59	1.47	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	44.32	2.17	2.08	2.25	0.92	1.58	0.17	0.17	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.11	3.27	1.87	2.34	0.00	1.40	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	47.78	2.30	1.01	2.73	1.44	0.72	0.86	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	46.66	1.53	2.29	2.80	1.53	1.27	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	25.95	3.57	1.32	2.82	0.94	0.56	0.19	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.94	1.68	0.98	2.24	0.84	1.54	0.14	0.00	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.70	3.85	2.18	2.93	1.59	1.09	0.00	0.08	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	42.38	1.90	0.95	2.38	0.00	1.90	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.34	2.20	1.47	3.67	1.47	1.47	0.98	0.24	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.93	9.72	4.20	5.30	3.54	0.66	1.99	0.00	1.33	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	24.87	1.46	1.76	1.46	0.59	0.88	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	40.23	5.44	3.30	3.69	3.69	1.94	0.97	0.39	0.39	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.64	0.79	3.17	1.85	1.32	2.91	0.79	0.00	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.51	4.09	1.86	1.86	0.74	0.37	3.35	0.00	1.86	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	36.29	2.52	3.95	3.95	2.87	1.80	1.08	0.72	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	35.49	1.42	0.85	1.42	2.84	1.70	0.57	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	23.63	0.00	0.79	0.79	1.18	2.36	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	33.52	3.81	3.56	5.33	2.54	3.56	2.79	0.51	0.76	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	38.73	5.19	3.19	3.99	2.40	3.19	5.19	0.00	0.00	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	35.11	3.76	2.93	4.18	1.67	1.25	0.84	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	22.00	1.83	2.29	0.92	2.29	2.75	1.38	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	44.61	2.86	1.85	3.20	1.35	1.51	0.67	0.00	0.17	0.50
Synoviocyte, donor2	11368-117I9	63.86	3.02	2.85	4.69	1.17	2.51	0.34	0.17	0.34	0.17
Synoviocyte, donor3	11440-118H9	36.86	2.23	2.23	2.01	0.89	0.67	0.45	0.00	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	50.03	5.00	2.14	3.22	2.14	2.50	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	91.17	1.98	3.96	3.96	1.98	1.98	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	70.85	8.34	6.25	4.63	3.70	2.32	0.00	0.46	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	42.22	1.65	1.79	1.65	1.36	1.22	0.50	0.07	0.07	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	25.13	0.77	1.16	0.00	0.39	0.00	0.00	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	32.64	1.15	0.57	1.15	0.00	0.57	0.57	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	105.43	5.66	7.75	7.26	4.06	3.20	0.86	1.23	0.49	1.35
Urethra, donor2	10319-105A4	80.93	8.99	10.79	10.79	12.59	5.40	0.00	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	44.90	0.80	2.92	1.06	3.72	2.13	0.27	0.27	0.00	0.27
Urothelial Cells, donor2	11600-120H7	34.45	1.20	1.20	1.20	0.80	1.20	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	42.63	0.69	2.29	1.60	1.83	2.52	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	67.09	0.67	3.57	2.01	1.78	2.90	0.00	1.56	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	142.37	0.00	8.01	1.78	2.67	3.56	0.89	9.79	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	148.68	0.00	10.01	1.43	2.86	2.86	0.00	10.01	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	154.70	2.05	5.48	1.37	1.37	5.48	0.68	4.11	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	87.12	0.00	6.54	0.69	2.75	3.79	0.00	2.75	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	76.11	0.00	7.55	0.58	2.91	4.65	0.00	4.65	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	125.99	0.00	14.58	0.00	3.12	2.08	0.00	3.12	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	114.72	0.92	6.42	1.84	4.59	1.84	0.00	4.59	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	129.63	3.65	4.56	0.91	5.48	4.56	0.00	5.48	1.83	2.74
Wilms' tumor cell line:G-401	10809-111A8	50.33	6.17	2.84	3.82	3.58	1.73	0.62	0.12	0.00	0.49
Wilms' tumor cell line:HFWT	10597-108E3	89.76	14.08	15.84	8.80	13.20	4.40	2.64	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	41.06	1.96	4.47	1.12	2.79	3.07	0.00	0.28	0.00	0.56
achilles tendon, donor2	10292-104G4	97.13	4.13	4.13	2.07	0.00	0.00	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.93	0.51	3.57	0.00	1.53	1.53	0.25	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.97	0.46	3.02	0.46	1.39	3.71	0.00	0.70	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	62.92	1.19	6.17	0.36	3.44	6.29	0.36	1.19	0.12	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.12	0.54	1.63	0.54	0.27	4.90	0.00	0.54	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.48	1.12	4.78	1.97	2.25	4.22	0.00	0.56	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.87	1.27	2.11	0.63	1.90	1.69	0.00	0.42	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	64.51	2.72	6.26	0.82	5.17	3.27	0.54	0.54	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	41.86	0.88	4.85	0.44	1.32	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.33	1.23	1.23	0.00	2.86	1.63	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.87	1.94	6.99	1.94	4.27	3.88	0.39	1.16	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.96	0.37	0.55	0.18	0.00	1.10	0.18	0.00	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	0.00	3.90	0.00	11.70	7.80	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	55.31	3.49	5.81	2.79	2.56	3.25	0.70	0.23	0.00	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	51.78	0.52	4.40	0.52	0.78	2.59	0.00	0.78	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.39	0.88	1.46	0.29	0.88	2.05	0.00	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	41.83	0.93	2.79	0.46	0.93	2.32	0.46	0.00	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.07	0.41	2.06	0.41	0.82	1.65	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.95	0.61	3.07	0.31	2.15	1.23	0.00	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	39.26	0.00	3.41	0.43	2.13	1.71	0.00	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	46.71	0.91	1.52	0.91	2.12	3.94	0.00	1.52	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	58.01	0.96	2.89	0.24	1.44	3.13	0.00	0.72	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.83	0.22	1.34	1.11	1.78	0.67	0.22	0.22	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	39.02	1.33	6.34	0.00	6.34	3.00	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	81.76	7.43	7.43	7.43	7.43	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	39.93	1.51	2.64	0.75	2.64	1.13	0.38	0.00	0.38	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	95.51	2.62	6.98	1.74	3.49	7.41	1.31	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	101.22	3.75	26.24	3.75	31.87	11.25	1.87	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	74.65	0.94	2.59	0.71	1.65	3.30	0.00	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	56.93	5.43	3.26	6.05	1.09	2.02	2.02	0.16	1.24	2.64
adipose, donor1	10184-103D4	43.98	41.64	7.04	15.25	5.28	4.69	3.52	0.59	14.66	18.77
adipose, donor2	10185-103D5	40.96	38.52	13.38	9.73	6.08	8.92	2.43	2.03	4.87	9.73
adipose, donor3	10186-103D6	62.90	23.42	12.80	10.07	11.98	9.26	4.08	1.91	3.81	8.17
adipose, donor4	10187-103D7	173.35	14.73	5.20	6.93	3.47	2.60	4.33	0.00	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	89.33	2.68	3.47	0.63	6.31	5.37	0.32	0.47	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	105.49	7.28	0.00	0.00	0.00	3.64	0.00	0.00	0.00	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	37.09	0.13	1.60	0.93	0.27	1.07	0.00	0.27	0.00	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	43.59	1.79	1.43	0.71	1.79	2.50	0.00	0.00	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	65.15	1.16	2.78	0.46	1.16	0.70	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	67.96	1.35	2.03	2.37	0.34	2.03	0.34	0.34	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	72.18	0.29	3.54	0.00	0.88	2.36	0.29	0.29	0.29	0.00
amygdala - adult, donor10196	10167-103B5	59.29	9.49	11.86	3.56	5.93	10.67	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	126.53	13.59	13.99	8.11	8.92	6.08	1.42	1.01	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	34.86	5.16	4.20	3.55	6.13	1.94	0.65	0.00	0.00	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	60.61	7.89	3.18	9.17	2.55	1.91	1.40	0.25	0.13	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	44.57	0.22	3.75	0.88	2.43	2.65	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	63.13	11.02	9.35	5.01	6.35	4.01	0.67	0.33	0.00	1.67
aorta, adult, pool1	10052-101G7	108.07	4.71	6.67	3.73	1.96	3.14	0.59	0.20	0.00	1.57
appendix, adult	10189-103D9	110.61	10.87	8.54	8.15	1.16	6.99	0.39	1.16	0.39	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.60	8.94	6.88	4.82	5.50	6.88	0.69	0.00	0.69	1.38
artery, adult	10190-103E1	77.45	8.15	4.08	13.59	1.36	2.72	1.36	0.00	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	75.33	4.64	5.07	4.20	5.22	7.24	0.29	0.43	0.00	0.43
b cell line:RPMI1788	10427-106D4	57.10	2.23	2.68	2.53	2.68	2.83	0.45	0.30	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	51.33	4.72	2.77	1.39	2.50	0.83	0.28	0.55	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	59.94	2.18	1.79	3.37	1.79	2.58	0.10	0.20	0.00	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	34.15	1.84	2.68	1.00	3.51	1.00	0.33	0.00	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	60.96	1.12	2.80	1.12	1.68	3.91	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	95.60	9.99	2.93	10.21	1.52	2.72	1.85	0.33	0.98	1.63
blood, adult, pool1	10053-101G8	110.73	8.86	4.43	6.64	4.43	4.43	0.00	15.50	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	105.33	1.71	2.57	0.00	4.28	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	47.24	4.72	5.40	4.05	4.72	2.02	0.67	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	61.50	11.28	9.23	9.23	6.15	2.05	1.03	0.00	0.00	3.08
brain, adult, pool1	10012-101C3	51.45	7.68	5.12	9.80	2.90	4.01	1.22	0.45	0.45	0.78
brain, fetal, pool1	10085-102B4	53.43	21.37	10.69	2.67	5.34	5.34	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	120.58	1.98	17.18	0.66	12.22	4.63	0.99	0.66	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	70.40	1.50	4.87	1.75	2.50	2.25	0.12	0.75	0.00	0.25
breast, adult, donor1	10080-102A8	97.23	10.10	6.31	5.05	3.79	1.26	1.26	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	26.55	0.89	2.29	0.38	0.51	0.89	0.51	0.00	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	41.74	3.71	2.47	0.62	1.55	1.24	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	33.38	2.30	1.61	2.53	1.15	0.92	0.23	0.00	0.00	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.53	0.24	4.12	0.48	1.45	0.97	0.73	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	19.75	1.88	3.29	0.47	1.41	1.88	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	72.30	3.94	8.64	1.31	6.45	4.27	0.00	0.22	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	23.13	1.27	4.44	0.32	1.58	2.22	0.00	0.32	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	51.90	12.78	7.45	7.99	2.93	3.73	0.53	0.00	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	54.11	10.36	9.21	4.61	8.06	3.45	0.00	3.45	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	84.00	9.87	8.03	9.20	4.85	5.19	0.50	4.35	0.00	1.34
caudate nucleus, adult, donor10258	10379-105H1	32.09	9.17	3.06	3.06	0.00	5.35	0.00	3.06	0.00	2.29
caudate nucleus, newborn, donor10223	10354-105E3	45.41	5.86	6.96	6.23	7.69	3.30	0.73	1.46	0.00	2.20
cerebellum - adult, donor10196	10173-103C2	131.10	2.91	5.83	2.91	5.83	5.83	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	155.01	11.10	13.24	6.62	8.75	7.26	0.21	0.64	0.21	0.85
cerebellum, adult, pool1	10083-102B2	61.40	4.14	3.10	2.76	2.41	3.45	1.03	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	97.14	7.47	7.47	9.96	9.96	4.98	4.15	0.00	0.00	3.32
cerebral meninges, adult	10188-103D8	54.21	7.82	4.54	5.80	2.52	2.52	1.01	0.50	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	53.35	8.04	4.39	6.58	3.65	2.19	0.00	0.73	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	64.85	8.34	4.03	4.60	2.44	2.44	1.29	0.14	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	55.02	1.66	6.13	0.33	4.47	2.98	0.99	0.50	0.33	0.66
cervix, adult, pool1	10013-101C4	74.02	11.44	6.61	11.13	2.94	4.51	3.15	0.63	1.05	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	67.30	2.51	3.62	4.32	3.07	3.34	0.14	0.70	0.00	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	65.31	5.23	3.92	10.45	5.23	2.61	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	44.12	4.10	4.60	6.84	4.35	6.09	0.75	0.75	0.99	1.24
choriocarcinoma cell line:SCH	10785-110H2	74.30	2.34	2.96	3.08	2.96	4.93	0.62	0.99	0.12	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	52.65	1.66	1.90	1.90	3.56	4.27	0.24	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	57.27	0.57	2.56	1.71	1.42	2.56	0.00	0.28	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	64.13	4.28	5.37	3.38	3.88	2.39	0.60	0.30	0.89	2.78
chorionic membrane cells, donor3	12240-129G8	59.89	1.10	1.65	2.75	0.55	0.55	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	2.02	0.00	1.01	0.00	2.02	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.20	1.54	7.11	0.77	4.61	3.84	0.77	0.00	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	54.06	3.17	4.01	0.63	3.38	4.22	0.42	0.42	0.00	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	32.36	1.03	3.60	0.26	1.54	2.31	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.54	0.97	2.66	0.97	1.69	2.42	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.85	1.43	5.09	0.81	1.83	4.07	0.41	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	35.33	1.18	2.36	0.88	1.77	1.18	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	94.35	1.56	9.38	1.56	3.91	12.25	0.00	1.30	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	54.63	1.83	2.06	2.51	1.37	3.43	0.46	0.46	0.69	1.83
clear cell carcinoma cell line:TEN	10636-108I6	41.82	3.99	1.56	1.74	2.26	0.69	0.17	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	47.96	8.60	4.94	5.31	6.59	3.29	0.00	0.18	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	36.11	9.12	5.32	3.42	3.04	5.32	0.76	1.14	0.00	0.38
colon, adult, donor1	10082-102B1	95.20	7.14	8.33	2.38	2.38	2.38	1.19	0.00	1.19	3.57
colon, adult, pool1	10014-101C5	84.84	10.58	8.11	7.17	3.53	4.23	7.52	0.59	0.12	3.88
colon, fetal, donor1	10070-101I7	111.24	12.98	11.12	6.18	4.94	4.33	3.09	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	435.43	4.58	18.33	4.58	27.50	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	52.69	3.40	5.95	2.12	9.35	5.95	0.00	0.42	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	30.04	3.77	2.72	1.06	2.57	1.51	0.15	0.15	0.30	3.47
cord blood derived cell line:COBL-a untreated	10449-106F8	25.95	1.55	2.54	1.13	2.12	1.13	0.14	0.28	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	115.76	13.49	9.73	10.72	6.85	5.64	0.88	1.44	0.11	0.55
cruciate ligament, donor2	10295-104G7	90.77	6.48	6.48	3.24	1.62	1.62	3.24	0.00	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	93.90	24.88	6.42	8.03	4.01	4.01	1.61	0.00	0.00	1.61
diencephalon, adult	10193-103E4	56.40	8.88	3.84	4.08	2.88	2.40	0.24	1.68	0.48	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.61	0.92	0.92	0.23	0.69	0.92	0.23	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	65.90	2.31	6.41	3.08	5.64	1.54	0.51	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	55.85	1.93	2.89	3.13	4.09	2.41	0.00	0.72	0.48	0.48
ductus deferens, adult	10196-103E7	104.15	4.49	5.48	3.49	1.50	2.49	1.00	0.00	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	5.76	8.64	2.88	2.88	7.20	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	77.98	6.62	10.30	5.89	3.68	2.94	0.00	0.00	0.74	2.21
dura mater, adult, donor1	10041-101F5	146.51	7.27	5.53	8.42	2.31	3.72	0.41	0.41	0.25	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	58.41	13.55	3.55	11.10	9.99	2.89	4.66	0.89	2.00	5.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	26.80	4.16	2.72	2.01	1.29	2.01	0.29	0.43	0.57	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	82.01	2.47	3.08	4.93	0.62	3.70	0.00	0.00	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	51.16	1.82	1.21	1.21	1.21	1.51	0.30	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	68.85	3.09	2.16	2.78	3.40	3.40	0.31	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	135.29	1.31	1.31	0.00	2.63	6.57	0.00	0.00	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	111.28	29.16	12.74	19.11	17.43	4.69	1.68	0.67	0.00	3.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	93.52	3.62	3.81	2.36	1.99	5.07	0.72	0.18	0.18	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.94	0.80	3.86	0.80	4.82	2.25	0.00	0.48	0.00	0.80
epidermoid carcinoma cell line:A431	10426-106D3	60.69	1.89	5.67	2.11	6.11	3.45	0.44	0.22	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	69.18	2.97	4.29	2.20	3.08	2.86	0.44	0.55	0.00	0.00
epididymis, adult	10197-103E8	96.28	11.93	12.56	9.42	5.65	3.98	1.47	0.21	0.84	3.56
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	50.74	1.42	2.31	3.19	0.89	3.02	0.18	0.71	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	65.28	3.93	7.47	4.72	3.15	3.54	1.18	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.29	1.05	1.05	0.66	0.66	0.66	0.26	0.13	0.13	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	48.03	3.05	2.26	2.46	1.97	1.87	0.30	0.20	0.20	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.34	1.34	0.34	1.12	1.12	0.90	0.22	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	66.36	4.99	3.50	5.42	2.65	2.97	1.70	0.42	1.17	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	167.82	17.03	17.66	19.16	8.77	10.14	1.38	1.13	0.75	2.38
eye - muscle inferior rectus, donor1	10272-104E2	62.78	4.83	0.00	4.83	2.41	2.41	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	65.23	12.63	2.10	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	35.72	5.95	4.46	2.98	4.46	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	61.91	5.73	5.73	5.73	6.88	1.15	3.44	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	120.96	11.66	7.29	4.37	0.00	1.46	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	74.49	9.41	7.12	5.59	4.32	2.03	0.51	0.25	0.00	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	33.85	2.44	1.03	1.54	1.54	2.18	0.38	0.13	0.13	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	73.13	4.04	3.09	3.56	1.42	3.56	0.95	0.00	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	57.23	7.13	9.57	7.88	3.85	4.69	1.31	0.47	0.09	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	71.76	4.80	5.70	5.10	4.80	9.61	0.30	0.30	0.00	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	108.63	5.49	5.12	5.85	3.47	3.38	0.46	0.09	0.09	0.46
gall bladder, adult	10198-103E9	117.82	8.45	4.83	7.24	3.38	3.38	0.48	0.24	0.97	1.93
gamma delta positive T cells, donor1	11937-126A2	61.20	0.54	3.76	0.54	0.54	2.15	0.54	1.07	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	84.41	1.87	5.60	4.11	2.99	4.48	0.75	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.78	4.86	3.80	1.48	3.59	4.65	0.00	0.63	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	118.18	5.80	8.70	0.58	6.77	1.16	0.39	0.19	0.00	0.97
gastric cancer cell line:AZ521	10549-107H9	67.55	11.48	4.59	4.43	7.71	5.25	0.66	0.49	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	52.17	6.41	3.66	2.75	2.75	2.75	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	70.14	11.88	11.65	5.71	20.10	4.11	0.69	0.46	0.46	1.37
giant cell carcinoma cell line:LU65	10487-107B1	37.98	1.84	1.72	1.84	1.38	1.61	0.11	0.23	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	89.29	12.32	5.18	9.24	3.78	3.64	0.56	0.42	0.42	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	71.58	2.00	4.74	1.25	6.24	4.24	0.25	0.25	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	46.55	1.27	5.81	1.79	3.59	4.12	0.32	0.11	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	39.74	1.69	8.15	1.69	4.92	3.37	0.42	0.14	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	41.17	2.76	2.76	2.32	2.54	1.77	0.44	0.11	0.22	0.55
glioma cell line:GI-1	10413-106B8	51.84	3.22	4.39	6.44	3.51	4.69	0.29	0.00	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	67.79	10.93	3.64	8.75	5.83	6.56	0.73	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	150.36	12.94	10.25	10.01	6.35	4.39	0.49	0.98	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	39.71	1.37	4.11	4.11	1.37	1.37	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	32.51	2.66	2.66	3.73	4.26	3.73	0.53	1.60	0.00	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	369.52	0.00	24.47	9.79	4.89	17.13	2.45	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	62.72	4.16	6.08	1.60	1.92	3.20	0.32	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	39.94	7.35	1.84	1.38	3.21	3.21	4.59	0.00	0.00	1.84
hIPS +CCl2, biol_rep2	14384-156C1	27.44	7.32	4.57	0.46	1.37	1.83	1.37	0.00	0.00	1.37
hIPS +CCl2, biol_rep3	14385-156C2	21.90	5.15	2.58	0.00	3.86	2.58	2.58	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	14.37	2.87	2.87	0.00	2.87	4.31	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	27.43	4.80	2.06	0.00	4.12	1.37	2.06	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	39.72	8.83	5.52	3.31	2.21	3.31	0.00	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	32.76	0.57	2.30	0.57	0.86	2.87	0.29	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	98.06	8.67	3.29	5.68	1.49	0.90	0.60	0.60	0.60	1.79
heart - pulmonic valve, adult	10206-103F8	103.54	6.80	6.01	9.15	1.31	2.35	1.31	0.26	0.26	2.61
heart - tricuspid valve, adult	10207-103F9	203.16	17.49	9.99	17.49	7.49	4.16	0.83	1.67	0.83	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	85.70	4.49	4.49	1.84	2.45	4.90	0.00	0.00	0.20	1.02
heart, adult, diseased, donor1	10051-101G6	80.48	5.54	2.13	2.55	1.70	1.70	0.43	0.00	0.43	2.55
heart, adult, pool1	10016-101C7	95.44	6.67	3.22	6.44	2.99	2.07	1.38	0.46	0.46	0.69
heart, fetal, pool1	10046-101G1	94.88	17.87	9.96	8.42	4.62	4.42	1.23	0.31	0.21	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	104.59	6.79	11.72	2.16	4.94	2.47	0.31	0.31	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	51.13	20.22	15.46	3.57	17.84	8.32	1.19	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	61.10	6.30	9.83	2.87	11.49	5.97	0.22	0.77	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	62.75	5.46	13.35	5.10	8.74	7.16	0.12	1.34	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	70.03	6.27	12.83	3.44	10.71	5.76	0.10	0.81	0.00	0.30
hepatoma cell line:Li-7	10484-107A7	98.65	27.58	11.23	6.90	18.57	5.00	1.00	0.67	1.00	1.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	31.46	1.81	2.11	1.51	2.21	2.11	0.10	0.40	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	60.56	4.73	7.57	2.84	8.52	2.84	2.84	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	135.32	14.29	16.33	9.39	10.41	6.33	1.02	2.04	0.41	1.02
hippocampus, adult, donor10258	10374-105G5	28.38	2.49	9.46	0.00	4.48	2.49	1.49	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	35.95	4.93	6.70	6.34	9.16	3.17	1.06	2.11	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	9.77	1.83	5.49	3.05	4.88	0.61	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.69	7.27	1.96	4.52	3.14	1.96	0.98	0.00	0.20	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	24.88	5.59	2.54	2.29	3.55	2.54	0.51	0.00	0.00	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	43.98	24.81	9.02	6.20	10.71	11.28	4.51	0.00	4.51	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	51.64	34.86	10.59	17.82	13.69	8.00	5.42	0.26	6.46	10.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.62	23.92	4.93	9.11	7.97	5.31	4.18	0.00	3.04	6.07
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.28	25.11	12.55	11.39	15.18	9.63	3.50	1.17	5.55	8.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	50.41	28.01	15.08	14.86	16.59	9.48	2.37	0.86	4.95	7.97
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	49.63	30.45	13.76	7.09	12.10	9.18	2.50	2.09	3.75	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.83	10.66	4.74	9.71	6.39	5.68	0.95	0.24	0.95	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.20	18.64	11.73	10.45	10.45	10.93	2.57	0.32	2.89	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	14.81	8.08	8.08	7.41	8.75	2.02	0.00	2.02	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	21.75	6.10	1.88	3.60	3.91	3.44	0.94	0.00	0.31	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	4.42	1.97	2.46	3.44	2.95	0.00	0.98	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	2.62	1.75	2.62	2.62	0.87	0.87	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	55.56	35.32	14.13	13.75	14.13	9.55	4.01	0.76	5.92	14.70
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	47.53	29.65	9.16	5.23	13.08	9.59	4.80	1.31	5.67	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	31.98	30.49	11.49	6.50	10.49	5.00	4.50	0.00	6.50	16.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.45	39.00	8.85	17.14	4.14	5.09	2.45	0.57	2.83	7.35
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	42.74	43.65	14.55	10.91	6.37	5.46	3.18	0.00	4.55	5.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	34.77	25.37	11.59	16.29	4.07	5.64	2.82	0.31	6.89	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.62	19.60	8.98	7.19	7.51	6.70	1.47	0.33	1.96	6.21
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.10	15.68	8.42	8.13	5.23	6.10	2.61	1.16	3.19	6.68
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.68	14.65	11.36	8.67	8.07	11.96	1.79	0.30	2.99	4.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	25.13	5.54	1.48	2.96	2.96	3.14	1.85	0.18	0.37	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.96	7.13	2.85	3.14	3.14	2.85	1.14	0.00	0.29	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	20.82	8.57	1.63	3.27	2.86	3.67	0.82	0.41	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.73	21.83	11.62	9.15	10.21	6.69	3.17	0.00	4.58	8.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	33.57	18.05	12.04	5.07	10.45	5.70	2.85	0.63	3.17	4.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.06	18.76	8.47	6.96	11.50	7.87	1.82	1.51	4.24	7.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.82	19.13	7.24	8.79	8.27	7.24	2.59	0.52	3.62	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.88	18.60	10.63	3.98	8.63	4.65	1.99	1.33	1.99	6.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.58	14.37	7.95	8.21	7.44	6.16	1.80	0.51	2.05	3.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	27.87	11.50	6.39	5.88	4.86	5.88	1.28	1.02	1.28	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.10	21.20	3.79	6.82	8.33	6.82	3.03	0.00	3.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.52	10.08	6.39	7.39	9.07	7.73	0.67	0.00	0.67	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.88	11.11	2.17	3.38	2.66	3.38	2.66	0.24	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	8.91	1.34	3.57	1.34	0.89	0.45	0.00	1.34	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.00	12.20	0.98	3.41	1.95	3.90	1.95	0.00	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.90	30.26	9.78	9.17	11.61	7.95	3.06	0.61	4.58	11.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	29.28	0.00	9.76	13.01	6.51	0.00	0.00	19.52	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.81	15.89	4.63	9.27	5.63	4.96	3.31	0.00	8.60	9.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	17.51	11.49	8.21	10.95	7.11	1.64	1.09	4.93	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.46	14.84	10.86	9.77	10.49	7.60	1.09	1.09	3.62	6.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.72	19.93	8.19	3.91	7.83	7.12	2.85	0.00	2.49	5.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	16.71	7.16	7.16	13.13	5.97	2.39	1.19	3.58	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	41.03	17.61	15.44	8.94	12.05	7.99	2.03	1.49	3.79	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.52	14.01	10.24	7.81	8.62	6.20	1.89	0.54	3.23	2.69
immature langerhans cells, donor1	11904-125F5	90.08	0.97	3.15	1.45	5.09	2.18	0.24	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	87.13	0.00	8.71	0.00	4.75	5.54	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	66.62	10.03	12.11	6.81	6.06	6.25	0.95	1.23	0.19	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	37.72	2.60	4.88	0.33	1.95	2.60	0.98	0.33	0.00	0.65
kidney, adult, pool1	10017-101C8	81.30	5.21	4.71	6.21	3.00	4.51	1.00	0.30	0.30	1.00
kidney, fetal, pool1	10045-101F9	107.09	13.16	13.16	7.78	10.19	7.71	0.64	1.27	0.07	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	136.77	26.27	10.08	14.34	9.94	10.51	2.27	0.57	0.43	3.27
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.59	1.80	0.69	1.52	1.38	0.83	0.00	0.14	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	70.28	4.40	2.94	2.57	2.02	3.12	0.18	0.00	0.18	0.55
left atrium, adult, donor1	10079-102A7	71.92	9.81	3.81	8.17	2.18	2.72	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	60.17	5.06	2.02	4.55	2.02	1.01	0.51	0.51	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	54.45	5.75	4.92	2.74	4.38	2.46	0.55	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	39.16	3.95	1.44	2.51	1.44	1.44	1.44	0.00	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	30.98	1.63	4.89	1.63	2.17	0.54	1.09	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	34.72	1.21	1.94	2.67	1.46	0.97	0.49	0.49	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	64.82	9.41	5.23	4.18	4.18	9.41	2.09	2.09	0.00	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	154.89	8.97	8.38	4.96	11.10	4.13	0.47	0.47	0.12	1.06
liposarcoma cell line:KMLS-1	10782-110G8	54.99	2.03	3.59	1.56	3.12	2.50	0.16	0.47	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	82.24	8.16	9.14	3.90	7.07	6.82	0.61	0.49	0.00	0.49
liver, adult, pool1	10018-101C9	86.54	4.86	7.78	12.80	5.02	2.43	1.46	0.16	3.40	1.46
liver, fetal, pool1	10086-102B5	65.85	4.70	2.82	6.58	0.94	5.64	0.00	0.00	0.00	3.76
locus coeruleus - adult, donor10196	10182-103D2	74.95	13.56	8.02	12.98	6.42	5.69	0.73	0.44	0.00	1.17
locus coeruleus, adult, donor10252	10165-103B3	103.53	8.49	8.67	4.61	4.24	2.95	0.74	0.92	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	42.88	7.05	6.21	3.67	2.82	4.23	0.28	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	27.76	7.15	6.31	9.67	5.05	3.79	1.68	0.00	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	47.33	3.18	2.08	1.94	1.38	1.80	0.14	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	64.11	1.38	9.65	3.45	6.89	8.96	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	104.00	13.58	5.40	8.17	4.48	2.77	0.92	0.13	0.40	1.32
lung, adult, pool1	10019-101D1	84.11	6.50	4.25	8.62	3.54	3.54	3.54	0.59	0.95	2.01
lung, fetal, donor1	10068-101I5	134.71	21.69	15.41	2.85	5.42	4.85	2.85	1.14	0.57	1.71
lung, right lower lobe, adult, donor1	10075-102A3	99.89	7.33	6.87	7.33	3.67	3.67	1.83	0.46	0.00	2.75
lymph node, adult, donor1	10077-102A5	63.43	4.26	6.15	5.21	2.84	4.26	2.84	0.47	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	27.18	0.88	1.10	0.88	0.66	1.32	0.44	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.96	1.36	1.51	0.30	0.91	0.91	0.30	0.15	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	111.28	5.10	8.49	5.10	6.80	0.85	0.00	1.70	0.00	5.10
mature adipocyte, donor1	12231-129F8	123.87	3.11	3.55	4.88	1.33	2.66	1.33	0.89	0.44	0.89
mature adipocyte, donor2	12232-129F9	76.99	3.74	2.70	5.40	2.08	1.45	1.04	0.21	0.42	1.04
mature adipocyte, donor3	12233-129G1	96.96	2.13	1.90	4.98	2.61	1.66	0.24	0.47	0.47	1.66
mature adipocyte, donor4	12234-129G2	73.96	5.79	2.37	4.21	1.58	0.79	1.32	0.26	0.26	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	145.58	5.96	18.11	6.19	13.10	11.44	2.14	0.00	0.24	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	38.35	3.38	9.02	4.51	1.13	2.26	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	117.52	7.91	9.38	4.97	5.33	3.49	1.10	0.74	0.37	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	32.72	4.45	6.67	2.86	3.18	5.08	0.64	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	37.53	5.97	2.56	3.84	1.71	2.56	1.28	0.43	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	40.50	8.27	8.78	9.79	3.88	6.58	1.35	0.51	0.00	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	126.70	8.70	13.79	6.15	7.00	4.24	1.49	0.85	0.21	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	1.93	5.78	0.00	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	37.33	3.59	5.03	2.87	4.67	4.67	2.15	0.72	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	60.35	14.28	4.54	7.14	3.89	5.84	1.95	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	121.37	10.22	10.37	6.04	4.95	4.18	0.62	1.08	0.31	1.08
medulla oblongata, adult, pool1	10038-101F2	100.48	12.33	9.96	10.61	4.49	5.22	0.33	1.39	0.08	0.41
medulla oblongata, newborn, donor10223	10361-105F1	57.63	4.17	5.21	8.68	4.51	5.90	0.35	0.35	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	52.03	8.41	3.54	5.76	1.99	5.31	0.22	0.22	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	47.69	1.59	4.89	0.98	4.89	2.93	0.24	0.24	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	63.97	10.06	5.61	8.77	3.59	4.31	1.58	0.43	1.01	2.16
melanoma cell line:G-361	10465-106H6	36.10	11.94	3.53	6.52	3.26	2.44	4.89	0.27	2.17	1.90
meningioma cell line:HKBMM	10691-109F7	45.95	1.27	0.54	1.45	0.72	1.63	0.00	0.00	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	63.44	3.52	5.29	4.41	5.29	7.93	0.00	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	53.92	2.33	7.78	1.04	6.74	11.67	0.26	1.56	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.19	3.07	1.38	1.99	0.92	1.07	0.31	0.15	0.31	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	59.44	4.54	3.27	2.54	2.54	1.27	0.55	0.36	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.03	1.24	1.24	1.24	1.24	1.66	0.41	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.00	2.39	0.98	1.97	0.84	1.12	0.42	0.00	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	39.67	3.66	3.27	1.73	1.73	1.54	0.39	0.19	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	43.73	4.16	4.16	2.08	0.00	2.08	0.69	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	62.47	4.29	0.86	4.46	0.69	1.37	1.03	0.00	0.51	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.31	3.22	3.45	2.65	1.04	1.38	0.58	0.46	0.23	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.08	3.58	2.25	1.99	0.66	1.46	0.27	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.00	1.76	0.81	2.03	0.27	0.95	0.14	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.41	1.99	1.99	2.99	1.85	2.28	0.00	0.00	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	46.44	5.27	1.65	3.95	2.31	3.62	1.32	0.00	0.33	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	55.07	2.49	2.63	2.21	1.80	3.46	0.00	0.55	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	29.32	1.05	1.40	1.40	2.09	1.75	0.35	0.35	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	36.75	1.63	2.86	1.02	1.02	1.22	0.00	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	5.03	3.95	2.52	2.16	1.80	0.72	0.00	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	45.52	1.97	2.48	2.48	0.62	1.14	0.21	0.21	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	34.20	1.60	2.74	1.82	3.42	1.60	0.91	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	27.27	2.10	1.68	1.68	1.68	1.68	0.00	1.26	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.81	2.54	1.94	2.09	1.20	1.20	0.00	0.30	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	49.37	2.63	1.93	2.71	1.75	2.45	0.26	0.35	0.26	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.50	2.21	1.10	2.58	0.37	2.21	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	40.06	4.01	2.29	3.72	2.58	2.58	0.86	0.29	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.47	3.37	1.68	0.84	0.42	2.11	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	39.73	1.83	0.91	2.28	1.37	1.37	0.46	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	41.95	2.81	2.05	1.02	1.28	2.30	0.26	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	42.67	3.14	4.45	3.40	1.05	1.83	0.52	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	41.90	1.23	3.39	2.16	1.23	3.08	0.00	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.48	1.65	2.35	1.41	0.94	2.59	0.47	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	35.54	2.71	3.72	2.37	1.02	4.40	0.34	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	40.48	3.54	1.96	1.57	0.79	2.75	0.79	0.39	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	43.09	3.24	2.78	3.24	0.93	2.32	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.01	2.88	4.33	2.60	1.73	2.31	0.00	0.00	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.50	2.90	1.78	2.01	0.67	1.34	0.22	0.00	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	39.18	2.88	3.36	2.16	0.48	2.88	0.48	0.72	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.80	2.93	5.87	2.93	7.33	2.20	1.47	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	35.58	2.35	2.69	2.35	1.01	0.67	0.34	0.00	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	39.30	2.05	2.87	2.05	1.23	1.23	1.23	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.79	0.43	0.86	1.29	1.72	1.29	0.86	0.00	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	2.73	2.73	2.73	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	10.33	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.28	2.92	0.97	1.62	0.97	1.30	0.32	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	8.73	4.36	1.45	1.45	0.00	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	5.33	2.67	2.13	1.07	2.67	1.07	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	1.64	2.45	0.82	0.00	3.27	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.71	1.94	1.55	2.33	2.33	1.55	1.17	0.00	0.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	2.10	4.20	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	1.99	1.99	1.99	0.99	0.99	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	25.50	1.78	3.56	1.78	0.00	2.37	1.19	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	3.66	3.66	1.22	1.22	1.22	2.44	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	1.90	3.80	3.17	0.00	1.27	1.90	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.94	0.69	1.38	1.72	1.72	0.69	1.38	0.34	0.69	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	2.15	2.15	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	33.41	2.44	1.22	1.63	1.63	1.22	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	2.38	0.79	0.79	2.38	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	1.77	1.18	0.59	0.59	1.18	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.05	0.31	2.18	1.25	0.62	0.00	0.31	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	0.00	4.01	1.34	1.34	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	21.29	3.55	1.18	1.18	0.00	3.55	1.18	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	27.54	2.07	0.69	1.38	0.69	2.75	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.76	1.98	0.99	0.99	2.47	0.99	1.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	0.00	3.36	2.24	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	1.27	0.64	0.64	1.91	3.82	0.64	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	1.61	1.61	0.00	0.81	2.42	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	4.36	2.18	2.18	2.18	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	6.34	1.27	0.00	1.27	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	8.50	1.82	3.64	0.61	1.21	1.82	0.00	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	9.04	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	53.54	7.41	3.29	2.47	0.82	3.29	2.47	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	20.83	4.37	2.18	1.19	1.19	1.59	0.40	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.88	2.60	0.97	1.95	0.97	2.60	0.65	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	7.13	2.04	5.09	1.02	2.04	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	119.15	7.74	6.96	4.64	4.64	1.55	0.77	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	120.01	2.36	4.49	4.96	2.83	2.60	0.24	0.71	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	101.70	10.66	12.28	5.79	9.50	3.24	0.00	0.93	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	0.00	4.27	4.27	8.55	0.00	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	34.52	1.44	2.67	1.44	2.77	0.31	0.51	0.10	0.00	0.41
mesothelioma cell line:Mero-25	10850-111F4	70.13	5.45	8.40	4.31	7.04	1.82	0.23	0.68	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	51.34	1.71	2.93	1.22	2.44	1.71	0.00	0.24	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	38.53	2.21	4.43	1.11	4.43	0.22	0.22	0.22	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	68.59	8.15	5.52	4.47	3.94	3.42	1.58	0.26	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	53.11	4.43	4.94	2.72	3.06	1.87	0.68	0.00	1.02	1.19
mesothelioma cell line:Mero-84	10855-111F9	49.80	2.27	6.57	2.53	6.07	1.77	0.25	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	49.48	3.52	6.63	2.90	2.07	2.69	0.62	0.41	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	39.92	3.64	2.82	2.15	2.82	1.16	0.17	0.00	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	53.03	3.44	4.34	3.26	5.25	1.63	0.18	0.54	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	59.96	3.42	3.07	3.42	1.54	2.39	0.34	0.00	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	44.53	2.04	3.05	2.29	3.31	1.53	0.25	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	25.77	1.63	3.26	1.96	2.94	0.33	0.65	0.00	0.00	1.30
mesothelioma cell line:ONE58	10858-111G3	49.04	7.04	1.63	1.35	2.98	1.08	0.54	0.00	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	55.47	2.69	3.07	0.77	3.07	2.49	0.38	0.38	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	56.66	1.47	3.66	0.24	2.44	1.59	0.73	0.24	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	64.43	1.97	4.85	0.90	2.87	2.33	0.36	0.36	0.54	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	143.98	5.88	13.06	3.59	6.86	4.24	1.31	1.31	1.96	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.80	2.33	1.91	0.64	2.12	2.54	0.42	0.42	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	117.71	4.61	4.38	2.30	3.69	1.84	1.38	0.46	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.49	2.09	3.43	1.14	3.04	2.28	0.95	0.00	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.28	0.74	3.14	1.11	1.48	2.96	0.74	0.37	0.00	0.18
myeloma cell line:PCM6	10474-106I6	68.20	2.57	3.36	2.37	1.38	1.98	0.79	0.79	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	80.66	1.01	5.58	0.00	4.57	5.07	0.51	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	43.74	1.57	2.16	0.78	1.57	2.94	0.00	0.00	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	66.30	1.11	4.12	1.34	1.45	0.67	0.00	0.22	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.86	1.18	3.46	0.74	1.40	1.91	0.22	0.15	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	112.05	1.66	2.76	1.10	1.66	1.66	2.21	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	73.16	22.32	8.74	8.74	5.75	9.43	0.92	0.46	0.46	1.15
neuroblastoma cell line:NB-1	10539-107G8	44.53	3.37	5.61	2.81	2.81	4.12	0.00	0.94	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	57.78	12.86	9.49	4.43	7.59	6.96	0.42	0.84	0.00	0.84
neuroblastoma cell line:NH-12	10555-107I6	63.55	9.32	5.40	4.29	5.22	5.96	0.19	0.37	0.00	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	42.23	1.42	3.80	0.47	1.66	2.85	0.00	0.95	0.00	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	42.76	3.01	5.86	1.27	3.64	3.80	0.79	0.48	0.16	2.53
neuroectodermal tumor cell line:TASK1	10774-110F9	31.20	1.81	7.45	1.21	2.42	7.45	0.00	1.21	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	114.44	5.72	15.89	1.27	8.90	10.17	0.64	2.54	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	62.55	4.52	3.46	2.93	3.46	1.60	0.27	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	1011.49	14.87	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	58.35	7.78	6.76	6.93	4.57	5.24	0.00	0.34	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	40.83	2.40	4.80	0.80	4.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	47.77	10.26	4.49	3.53	1.28	1.92	1.60	0.32	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	46.77	2.89	3.68	2.63	2.89	1.58	0.00	0.79	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	63.46	9.47	8.34	7.69	4.22	5.34	0.84	1.97	0.09	0.94
occipital cortex - adult, donor10196	10172-103C1	74.17	8.24	20.60	8.24	2.06	6.18	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	165.04	17.44	11.00	8.32	6.44	3.22	0.27	1.34	0.00	1.61
occipital cortex, newborn, donor10223	10355-105E4	41.85	6.19	5.82	2.91	6.19	2.55	0.00	0.00	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	51.95	11.81	9.18	6.04	1.31	3.41	3.41	0.26	0.79	1.31
occipital lobe, fetal, donor1	10073-102A1	93.97	7.72	23.60	3.00	13.30	16.31	3.00	4.72	0.43	2.15
occipital pole, adult, pool1	10036-101E9	57.79	8.51	5.99	4.73	3.31	4.97	0.55	0.16	0.16	0.63
olfactory region, adult	10195-103E6	68.40	7.26	9.93	7.83	3.25	4.20	0.57	0.57	0.38	0.76
optic nerve, donor1	10277-104E7	138.07	26.01	28.01	10.01	4.00	2.00	4.00	0.00	4.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	42.49	2.51	2.62	2.28	3.42	1.94	0.46	0.23	0.68	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	38.06	2.89	2.20	1.10	1.24	1.51	0.27	0.14	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.21	1.52	1.52	0.34	0.68	1.52	0.17	0.51	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	85.71	3.58	2.77	2.31	2.54	2.31	0.69	0.12	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	61.73	3.53	3.82	2.65	2.35	2.35	1.18	0.00	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	142.02	12.15	8.41	11.21	14.02	14.02	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	122.78	9.33	12.94	7.63	12.09	12.09	0.64	1.27	0.64	0.64
ovary, adult, pool1	10020-101D2	66.47	9.87	5.77	10.39	3.67	3.76	0.70	0.44	0.79	2.01
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	47.48	4.03	6.23	2.38	2.38	2.57	0.18	0.18	0.18	0.37
pancreas, adult, donor1	10049-101G4	88.42	1.88	6.58	0.94	3.76	2.82	0.00	0.00	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.09	0.84	3.07	2.52	1.96	3.35	1.40	0.00	0.84	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	41.91	3.24	2.90	2.56	1.19	0.51	0.51	0.68	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.72	4.97	4.14	4.31	1.82	2.81	0.33	0.00	0.17	1.16
paracentral gyrus, adult, pool1	10035-101E8	63.79	9.24	8.69	5.31	3.94	4.67	1.10	1.01	0.09	1.19
parietal cortex, adult, donor10258	10373-105G4	74.13	2.20	4.40	0.00	1.47	3.67	2.20	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	38.56	2.82	11.29	5.64	2.82	8.46	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	106.32	7.98	13.97	4.56	3.71	5.42	0.57	0.29	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	75.17	8.46	7.93	6.34	3.79	5.64	0.53	0.70	0.18	0.70
parietal lobe, fetal, donor1	10072-101I9	79.53	18.43	16.49	3.88	14.55	18.43	1.94	2.91	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	32.15	5.23	6.73	2.24	5.98	4.49	1.12	1.12	0.00	1.50
parotid gland, adult	10199-103F1	66.60	3.08	6.78	3.70	3.08	0.62	0.62	0.62	0.00	0.00
penis, adult	10200-103F2	73.05	10.21	5.91	7.52	3.76	1.61	1.07	0.54	0.00	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	79.95	2.05	3.72	0.74	2.23	4.28	0.37	0.56	0.00	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	67.89	6.12	4.81	1.89	4.66	3.79	0.44	0.58	0.00	0.87
pineal gland - adult, donor10196	10179-103C8	150.29	18.71	14.19	9.03	9.68	10.97	0.65	0.65	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	210.83	19.54	20.14	7.70	8.88	17.77	1.78	2.96	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	89.67	12.54	8.78	5.64	3.14	13.80	0.63	1.25	0.00	2.51
pituitary gland - adult, donor10196	10180-103C9	123.44	9.11	10.12	8.09	10.12	6.07	0.00	1.01	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	220.98	6.78	20.33	5.21	8.86	10.42	0.52	0.52	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	64.69	2.55	7.66	5.11	1.70	10.21	0.85	0.00	0.85	2.55
placenta, adult, pool1	10021-101D3	102.24	4.19	6.77	3.66	3.76	4.30	0.97	0.86	0.43	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	40.52	1.19	2.91	1.19	2.12	5.16	0.26	0.26	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	92.92	2.49	4.51	2.49	3.58	1.87	0.31	0.31	0.31	0.62
pons, adult, pool1	10033-101E6	60.08	5.16	6.54	4.82	3.96	3.79	0.34	0.34	0.09	0.86
postcentral gyrus, adult, pool1	10032-101E5	55.71	6.89	5.93	6.19	3.75	4.36	0.78	0.52	0.00	1.39
promyelocytes/myelocytes PMC, donor1	12132-128D8	257.24	2.09	14.64	0.00	16.73	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.95	2.33	1.31	1.17	1.60	2.77	0.58	0.15	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	61.35	3.27	5.63	3.63	4.90	3.99	0.73	0.36	0.00	0.36
prostate, adult, pool1	10022-101D4	67.57	6.17	7.16	7.80	2.36	3.81	0.27	0.18	0.63	1.90
putamen, adult, donor10196	10176-103C5	65.39	10.86	5.19	8.03	4.96	4.72	1.18	9.44	0.00	0.71
putamen, adult, donor10252	10152-102I8	52.94	3.92	5.88	1.96	5.88	1.96	0.00	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	26.23	3.28	3.28	2.19	6.56	1.09	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	45.42	6.52	4.83	5.32	1.93	3.38	0.72	2.66	0.00	0.24
putamen, newborn, donor10223	10365-105F5	26.24	3.00	2.25	1.50	5.25	0.00	0.75	2.25	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	113.46	5.82	6.11	7.56	5.24	4.95	1.16	1.16	0.29	0.29
rectum, fetal, donor1	10067-101I4	90.41	19.47	8.35	5.56	8.35	1.39	1.39	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.02	1.06	1.27	1.48	2.33	0.85	0.00	0.64	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	18.23	2.07	1.24	1.24	0.00	0.00	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	102.58	8.65	7.36	8.15	3.48	4.77	0.10	0.40	0.00	1.29
retinoblastoma cell line:Y79	10475-106I7	41.31	5.20	4.16	3.38	2.60	3.90	0.00	0.52	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	48.07	3.32	2.21	1.97	2.34	2.21	0.12	0.12	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	165.63	68.33	16.87	19.68	8.15	14.90	2.81	0.56	0.56	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	126.56	18.95	9.85	8.34	2.27	7.58	0.76	0.00	1.52	1.52
salivary acinar cells, donor1	11771-123I7	42.57	3.72	1.29	3.56	1.62	2.43	0.32	0.16	0.32	0.49
salivary acinar cells, donor2	11772-123I8	34.28	3.44	1.93	2.07	0.55	2.75	0.69	0.00	0.00	0.41
salivary acinar cells, donor3	11773-123I9	120.49	1.32	8.61	1.99	4.63	5.30	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	59.48	5.72	6.86	0.57	2.29	2.86	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.16	6.66	1.18	3.96	1.18	3.04	0.42	0.00	0.25	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	58.07	5.64	2.82	3.88	0.82	3.41	0.82	0.12	0.35	0.47
seminal vesicle, adult	10201-103F3	92.59	5.82	5.82	4.23	1.06	2.65	1.59	0.00	1.06	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	41.78	1.70	3.40	1.21	4.62	2.19	0.24	0.24	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.72	1.26	5.54	0.75	3.77	5.03	0.50	0.25	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	1.00	9.03	2.01	2.01	4.01	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	74.01	3.90	8.33	2.42	6.98	3.22	0.27	0.27	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	46.75	3.21	3.21	2.21	3.98	1.22	0.55	0.33	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.87	1.29	2.19	2.06	1.94	1.81	0.13	0.13	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	59.58	16.31	2.84	10.64	0.71	0.00	0.71	0.00	1.42	2.13
skeletal muscle, adult, pool1	10023-101D5	97.03	23.51	3.84	19.19	2.04	2.40	2.64	0.48	2.28	6.12
skeletal muscle, fetal, donor1	10066-101I3	72.36	16.08	7.04	10.05	5.03	5.03	0.00	0.00	0.00	2.01
skin, adult, donor1	10074-102A2	74.64	20.36	6.79	6.79	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	59.97	6.31	5.68	3.16	3.16	2.52	1.26	0.63	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	71.37	8.34	10.67	2.33	8.34	3.67	1.67	0.33	1.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.95	9.77	6.30	2.21	6.62	6.62	2.52	1.26	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	131.26	5.20	6.55	11.18	5.40	18.70	0.77	0.39	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	43.84	5.11	3.96	3.79	3.13	3.63	0.99	0.33	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	37.48	7.72	4.02	3.38	1.77	4.99	0.64	0.64	0.00	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	62.54	5.88	6.76	2.18	6.97	6.76	1.31	0.44	0.00	0.44
small intestine, adult, pool1	10024-101D6	106.07	6.93	10.63	8.84	6.81	5.26	2.51	0.60	1.43	2.75
small intestine, fetal, donor1	10064-101I1	66.83	5.90	8.35	2.70	3.44	2.21	0.25	0.74	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	48.21	4.10	8.72	1.54	8.72	3.59	1.54	0.00	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	113.46	7.75	4.39	3.62	2.07	1.81	0.78	0.00	0.00	0.78
somatostatinoma cell line:QGP-1	10781-110G7	182.25	5.63	18.76	1.07	13.94	5.63	1.88	0.00	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	83.50	15.14	8.72	11.24	7.80	3.90	1.61	0.69	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	133.26	18.53	8.28	9.46	6.31	4.73	0.00	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	26.98	4.84	6.92	0.00	6.92	2.77	0.00	3.46	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	84.16	21.95	9.76	8.54	8.54	4.88	1.22	0.61	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	47.76	8.27	1.84	4.59	4.59	2.30	0.46	0.46	0.00	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	103.95	7.17	4.63	1.79	2.39	1.94	0.75	0.30	0.15	0.15
spleen, adult, pool1	10025-101D7	65.42	4.52	6.39	7.27	3.19	4.74	0.33	0.33	0.77	1.65
spleen, fetal, pool1	10044-101F8	97.41	4.05	8.10	3.81	4.37	6.04	0.16	0.95	0.08	2.62
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.23	0.72	1.14	0.93	1.24	1.97	0.10	0.31	0.00	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	56.77	1.52	2.28	1.33	3.42	1.71	0.00	0.00	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	59.41	2.10	3.15	0.70	2.45	3.15	0.35	0.00	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	59.42	2.35	5.08	3.13	3.13	1.56	0.78	0.00	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	59.88	5.40	4.73	2.59	3.15	4.84	0.45	0.45	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	34.31	0.42	2.97	0.42	3.81	1.27	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	88.42	4.65	2.12	8.04	1.69	1.69	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	147.38	44.85	8.54	8.54	8.54	4.27	1.07	0.00	1.07	3.20
submaxillary gland, adult	10202-103F4	64.94	6.27	5.13	3.99	1.14	1.14	0.57	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	118.18	9.14	11.22	3.53	7.48	1.87	1.04	1.25	0.42	0.83
substantia nigra, adult, donor10258	10371-105G2	36.21	0.52	4.66	0.00	1.03	2.07	0.52	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	48.05	7.77	4.24	5.65	9.89	2.83	2.12	0.00	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	58.23	2.52	3.67	3.21	2.29	5.27	0.46	0.69	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	55.27	8.82	8.05	6.78	4.75	6.27	0.51	0.85	0.08	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	80.49	13.53	13.53	2.85	18.52	8.55	0.71	1.42	0.00	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	78.68	9.67	9.23	1.32	4.40	15.82	0.44	1.32	0.00	0.44
tenocyte, donor1	11763-123H8	59.35	3.84	1.40	1.75	1.75	3.49	0.35	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	56.84	1.53	2.29	3.05	1.14	1.53	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	48.56	1.48	2.59	0.37	1.85	0.74	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	53.03	9.69	3.74	4.76	7.14	3.06	0.85	0.51	0.00	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	47.63	6.17	2.62	3.70	4.78	5.24	1.08	0.31	0.46	1.39
teratocarcinoma cell line:PA-1	10807-111A6	56.88	19.06	6.82	4.96	6.35	5.11	1.24	0.31	0.00	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	57.00	9.27	8.89	3.94	10.16	5.08	2.67	0.51	0.63	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	76.01	16.64	10.21	10.21	8.70	6.43	1.89	0.00	0.00	3.78
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	127.49	11.12	11.78	10.58	10.36	7.53	1.64	0.33	0.55	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	35.83	9.12	9.77	4.23	2.61	3.58	0.65	0.00	0.00	1.63
testis, adult, pool1	10026-101D8	92.98	21.58	52.18	31.78	70.76	15.89	3.76	3.01	6.66	5.05
testis, adult, pool2	10096-102C6	129.91	44.21	75.33	16.69	112.77	26.16	1.80	4.51	0.00	4.51
thalamus - adult, donor10196	10168-103B6	70.66	5.52	13.25	5.52	5.52	4.42	0.00	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	119.09	9.53	9.85	7.19	7.97	3.91	0.16	0.31	0.47	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	4.62	10.78	6.16	3.08	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.83	2.80	3.95	3.29	1.32	2.47	0.49	0.33	0.33	0.66
thalamus, newborn, donor10223	10366-105F6	20.14	4.03	4.60	0.58	3.45	2.30	0.00	0.58	0.00	1.15
throat, adult	10209-103G2	74.40	5.49	4.74	6.49	3.00	4.24	1.25	0.25	0.00	1.25
throat, fetal, donor1	10061-101H7	76.79	12.80	8.84	7.01	4.88	4.57	0.30	0.61	0.00	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	40.74	2.58	3.78	4.77	1.39	2.38	0.00	0.20	0.20	0.00
thymus, adult, pool1	10027-101D9	83.71	6.26	8.05	6.76	2.09	10.04	1.49	6.66	0.89	1.39
thymus, fetal, pool1	10043-101F7	121.36	5.30	11.43	5.61	5.20	14.03	0.94	11.33	0.21	2.70
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.91	4.65	2.93	4.92	2.79	2.79	0.27	0.13	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	57.55	4.33	2.65	1.12	1.68	3.63	0.70	0.56	0.00	0.14
thyroid, adult, pool1	10028-101E1	89.21	6.07	7.28	5.41	1.49	4.11	1.49	0.65	1.31	1.59
thyroid, fetal, donor1	10060-101H6	110.21	7.12	16.61	6.86	6.59	6.59	0.26	0.53	0.26	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	15.40	9.24	12.32	0.00	3.08	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	59.07	5.58	2.79	4.19	2.33	2.33	1.16	0.47	0.23	0.23
tongue, fetal, donor1	10059-101H5	63.84	9.46	7.49	5.52	3.55	3.55	2.76	0.00	0.39	0.79
tonsil, adult, pool1	10047-101G2	82.95	2.60	6.91	2.30	2.10	5.41	0.60	2.00	0.00	1.10
trachea, adult, pool1	10029-101E2	73.86	4.50	4.58	5.56	2.70	1.88	0.82	0.57	0.74	0.90
trachea, fetal, donor1	10058-101H4	63.86	8.85	4.23	1.54	2.31	1.92	0.38	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	56.33	7.09	4.61	1.77	4.25	1.77	1.42	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	37.49	3.55	4.46	2.53	4.26	3.85	0.20	0.81	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	80.38	7.99	2.66	6.74	4.23	5.01	0.94	0.16	1.57	1.88
tridermal teratoma cell line:HGRT	10694-109G1	135.08	9.51	26.64	9.51	11.42	9.51	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	76.02	5.76	2.62	2.62	2.03	2.37	0.68	0.25	0.08	0.59
umbilical cord, fetal, donor1	10057-101H3	91.81	4.17	4.17	0.00	0.00	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	80.37	6.83	9.04	3.75	4.27	3.41	0.68	1.54	0.00	1.88
uterus, fetal, donor1	10055-101H1	60.92	10.75	9.73	6.14	4.61	4.10	0.51	0.51	0.51	0.51
vagina, adult	10204-103F6	107.92	1.94	7.11	7.75	1.29	3.23	0.00	0.65	0.00	2.58
vein, adult	10191-103E2	62.03	5.70	6.36	4.38	2.63	3.73	0.66	0.22	0.44	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	62.22	2.40	3.20	0.53	1.34	4.54	0.00	0.27	0.00	0.53